The QualityStocks Daily Thursday, June 13th, 2024

Today's Top 3 Investment Newsletters

QualityStocks(BSGM) $0.3950 +51.92%

BioMedWire(LGVN) $2.6900 +48.62%

360 Wall Street(BRTX) $1.9500 +44.44%

The QualityStocks Daily Stock List

BioSig Technologies (BSGM)

Broad Street, QualityStocks, StockWireNews, Small Cap Firm, AwesomeStocks, Fierce Analyst, MarketBeat, StockStreetWire, Stock Commander, BUYINS.NET, OTCBB Journal, MarketClub Analysis, SeeThruEquity Research, StockMarketWatch, WallstreetSurfers, StocksEarning, PennyStock Tweets, Penny Stocks Finder, SizzlingStockPicks, Stockgoodies, Wolf of Penny Stocks, Penny Picks, Penny Stock Craze, Winston Small Cap, Beacon Equity Research, TradersPro, The Wall Street Transcript, Make Penny Stocks Great Again, PennyStockLocks.com, Damn Good Penny Picks, Leading Penny Stocks, InvestorSoup, bullseyeoptiontrading, StockRockandRoll, Epic Stock Picks, StockHideout, Stock Preacher, SuperStockTips, BuzzStocks, Goldman Small Cap Research, DreamTeamNetwork, Mega Stock Alerts, Profitable Trader Authority, Pumps and Dumps, Wall Street Resources, The Online Investor, Street Picks, StocksImpossible, Stock News Now, Small Caps, Shiznit Stocks, PennyStockProphet, ResearchOTC, OTCtipReporter, ProTrader, PennyStockScholar, PennyStockLocks, Penny Stock General, Penny Stock Finder, Penny Stock 101, Penny Pick Finders and SECFilings.com News reported earlier on BioSig Technologies (BSGM), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

BioSig Technologies Inc. (NASDAQ: BSGM) is a medical device firm that is focused on the development and commercialization of medical devices, with a focus on its biomedical signal processing platform.

The firm has its headquarters in Westport, Connecticut and was incorporated in 2009, on February 24th by Kenneth L. Londoner. It serves consumers in the United States.

The company is party to a strategic collaboration agreement with the Mayo Foundation for Medical Education and Research, which entails the development of a machine learning and AI software solution for its real-time electrogram electrophysiology PURE EP systems. It is also party to a research agreement with the University of Minnesota, which entails the development of new therapies for the treatment of sympathetic nervous system illnesses.

The enterprise’s products includes its signal processing platform known as the PURE EP system, which combines software and hardware to address challenges linked to signal acquisition. The precise uninterrupted real-time platform is a computerized system that has been designed to acquire, digitize, filter, calculate, display, record and store intracardiac and electrocardiographic signals for individuals who are undergoing electrophysiology procedures. The platform allows electrophysiologists to observe signals and analyze them immediately. The enterprise is also focused on improving intracardiac signal acquisition and diagnostic information for the procedures of ventricular tachycardia and atrial fibrillation.

The firm recently released its PURE EP system clinical data, which show a 75% overall improvement in intracardiac signal quality. Its CEO noted that the results validated the clinical importance of the firm’s technology as well as the firm’s position for continued growth and success. The firm is focused on advancing the field of electrophysiology and bioelectronics medicine.

BioSig Technologies (BSGM), closed Thursday's trading session at $0.395, up 51.9231%, on 1,348,649 volume. The average volume for the last 3 months is 2.029M and the stock's 52-week low/high is $0.201/$0.547.

BioRestorative Therapies, Inc. (BRTX)

QualityStocks, MarketBeat, AwesomeStocks, TradersPro, PoliticsAndMyPortfolio, MarketClub Analysis, INO Market Report, 247 Market News, Streetwise Reports, Smartmoneytrading, ProActive Capital, Investor Ideas and InsiderTrades reported earlier on BioRestorative Therapies, Inc. (BRTX), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

BioRestorative Therapies, Inc. is a life sciences company focusing on adult stem cell-based therapies for various personal medical applications. The Company develops products and medical procedures utilizing cell and tissue protocols, primarily involving adult stem cells. OTCQB-listed, BioRestorative Therapies has its corporate, administrative, and laboratory operations in Melville, New York.

The Company’s aim is to become a leader in providing medical procedures using cell and tissue protocols, chiefly involving adult stem cells (non-embryonic), and enabling patients to undergo minimally invasive cellular-based treatments. BioRestorative Therapies is developing a cell-based therapy to target obesity and metabolic disorders utilizing brown adipose (fat) derived stem cells to produce brown adipose tissue (BAT). The intention of BAT is to mimic naturally occurring brown adipose depots that regulate metabolic homeostasis in humans.

Bio Restorative’s lead cell therapy candidate is BRTX 100. This product is formulated from autologous (or a person’s own) cultured mesenchymal stem cells collected from the patient’s bone marrow. The Company’s products and medical procedures include brtxDISC™ (Disc Implanted Stem Cells), its Disc/Spine Program, and ThermoStem®, its Metabolic Program.

brtxDISC™ is an investigational non-surgical treatment for bulging and herniated lumbar discs. brtxDISC™’s intention is for patients who have failed non-invasive procedures and face the prospect of surgery. ThermoStem® is a treatment using brown fat stem cells. ThermoStem® is under development for metabolic disorders, including diabetes and obesity.

BioRestorative Therapies is also the beneficiary of a patent granted for a licensed curved needle device (CND). The design of it is to deliver cells and/or other therapeutic products or material to a site having damage in need of facilitated repair.

BioRestorative Therapies, Inc. (BRTX), closed Thursday's trading session at $1.95, up 44.4444%, on 94,161,155 volume. The average volume for the last 3 months is 3.647M and the stock's 52-week low/high is $1.03/$7.13.

Aethlon Medical Inc. (AEMD)

Tip.us, Investor Ideas, QualityStocks, StockMarketWatch, Red Chip, MarketClub Analysis, Streetwise Reports, OTCPicks, BUYINS.NET, PennyStocks24, MarketBeat, FeedBlitz, TraderPower, TradersPro, StreetInsider, MicroCap Gems, AllPennyStocks, SmallCapVoice, RedChip, PennyStockRumors.net, Clutch Investments, Pennybuster, The Online Investor, PricelessPennyStocks, Stock Castle, Trading Concepts, BestStockChoice, TopPennyStockMovers, DrStockPick, Faisam Trader, StockBlogs, INO Market Report, PennyOmega, Investing Futures, WallStreet Advisors, InvestorPlace, InvestorsUnderground, SmallCapStockPlays, SmallCap Network, Nebula Stocks, Premium Stock Alerts, PennyTrader Publisher, Actual Gains and Investing Daily reported earlier on Aethlon Medical Inc. (AEMD), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Aethlon Medical Inc. (NASDAQ: AEMD) (FRA: EJU) is a medical technology firm that is engaged in the development of products that help in diagnosing and treating organ and life threatening ailments in the U.S.

The firm has its headquarters in San Diego, California and was incorporated in May 1998 by James A. Joyce. It is a part of the scientific and technical instruments manufacturing industry and operates in the health care industry, under the medical equipment and devices sub-industry.

The company is party to a collaboration agreement with the University of Pittsburgh which entails research on neck and head cancers. It operates through the ESI and Aethlon segments. The latter segment is involved in diagnostic business activities while the former segment deals with therapeutic business activities.

The enterprise offers a platform that develops medical equipment to target the selective removal of ailment-promoting particles from an individual’s circulatory system, known as ADAPT. Its product pipeline is made of an exosomal biomarker candidate known as TauSome, which diagnoses chronic traumatic encephalopathy in people. In addition to this, the enterprise also develops a clinical-stage immunotherapeutic device known as the Aethlon Hemopurifier, which removes life-threatening viruses and exosomes from the body’s circulatory system. These exosomes aid in the progression of infectious viral pathogens like Hepatitis C and HIV as well as cancer.

The firm recently published case studies of 2 coronavirus patients who were treated with its Hemopurifier, with its CEO noting that their device may play a crucial role in filtering out exosomes, adding that their device was able to clear the SARS-CoV-2 virus from both patients’ bloodstream. The device’s success in treating both patients may bring in more investors into the firm and push share prices higher.

Aethlon Medical Inc. (AEMD), closed Thursday's trading session at $0.687, up 31.4581%, on 30,544,235 volume. The average volume for the last 3 months is 21.135M and the stock's 52-week low/high is $0.3704/$5.00.

Bitfarms Ltd (BITF)

MarketClub Analysis, InvestorPlace, Schaeffer's, QualityStocks, MarketBeat, Zacks, Kiplinger Today, Wealth Daily, Trades Of The Day, TradersPro, The Online Investor, StocksEarning, StockEarnings, InvestorsUnderground and Daily Trade Alert reported earlier on Bitfarms Ltd (BITF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Bitfarms Ltd (NASDAQ: BITF) (CVE: BITF) is a blockchain infrastructure firm that is focused on mining for cryptocurrency tokens and coins in North America.

The firm has its headquarters in Toronto, Canada and was incorporated in 2017. It operates as part of the tech hardware and semiconductors industry under the technology sector, in the technology hardware sub-industry and serves clients across the globe.

The company holds expertise that goes beyond crypto-mining as its team, which includes experienced capital markets professionals and industrial-scale data center operators, also designs, builds and manages data centers and farm operations. Its objective is to build the infrastructure for the future by hosting and developing the ecosystem growing around technologies based on blockchain.

The enterprise operates and owns server farms which are made up of computers that mainly earn cryptocurrency from transaction fees and block rewards and processes as well as validate transactions on the Bitcoin Blockchain. These farms power the international decentralized financial economy, providing computing power to cryptocurrency networks like dash, litecoin, ethereum and bitcoin cash. The enterprise offers hosting of 3rd party mining hardware as well as electrician services to residential and commercial customers in Quebec, Canada.

The firm, which uses hydroelectric renewable electricity, recently began trading on the NASDAQ, making it the largest publicly traded Bitcoin miner in North America. Achieving this significant milestone will not only help the firm achieve its other objectives and help boost the company’s growth but also encourage more investments into the firm.

Bitfarms Ltd (BITF), closed Thursday's trading session at $2.81, up 15.6379%, on 54,303,480 volume. The average volume for the last 3 months is 59,766 and the stock's 52-week low/high is $0.919/$3.91.

TOMI Environmental Solutions (TOMZ)

QualityStocks, Stockpalooza, InvestorPlace, Nebula Stocks, Open Water Investments, Investor Relations, MarketBeat, Barchart, Research Driven Investor, Wealth Insider Alert, Serious Speculator, SmallCapVoice, Stock Exploder, Stock Traders Chat, StockEarnings and Penny stock Profitz reported earlier on TOMI Environmental Solutions (TOMZ), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

TOMI Environmental Solutions Inc. (NASDAQ: TOMZ) is an infectious disease control and bacteria decontamination firm that is engaged in the provision of environmental solutions for indoor surface decontamination.

The firm has its headquarters in Frederick, Maryland and was incorporated in 1979, on September 18th by Halden S. Shane. It serves consumers in the U.S. as well as internationally. The firm operates as part of the other specialty trade contractors’ industry and has four companies in its corporate family.

The enterprise’s products and services include the SteraMist Hospital disinfection cart which is used to disinfect patient rooms and operating rooms, emergency environments, ambulances and pharmacies in a health care facility or hospital; a remotely controlled system dubbed SteraMist Environment system which offers complete room decontamination/disinfection of a sealed space. It also provides a fully portable spray decontamination/disinfection system dubbed SteraMist Surface Unit which offers quick turnover for any affected space. In addition to this, the company also offers iHP corporate service disinfection, the SteraMist custom engineered system and the iHP plasma decontamination chamber. Furthermore, it also manufactures and sells a hydrogen peroxide-based mist dubbed SteraMist Binary Ionization Tech.

The company products and services are used in hospitals, the cannabis market, schools, ambulances, pharmaceutical firms, bio-safety labs, vivariums, office buildings, cruise ships, transportation industry and clean rooms, among others.

The firm recently secured a contract to install a iHP custom engineered system for sterilization in a major pharmaceutical firm in Europe. This project and its successful completion will present a significant opportunity for the firm to develop its relationship with the pharmaceutical company while also extending the firm’s consumer reach, which will boost investments into the firm as well as boost the company’s growth.

TOMI Environmental Solutions (TOMZ), closed Thursday's trading session at $1.07, up 14.0117%, on 417,715 volume. The average volume for the last 3 months is 711,757 and the stock's 52-week low/high is $0.5225/$1.39.

Lightwave Logic (LWLG)

QualityStocks, MarketBeat, StocksEarning, TradersPro, Trades Of The Day, Standout Stocks, PennyStocks24, StockOodles, StockGuru, SmallCapVoice, SmallCap Fortunes, OTCPicks, MarketClub Analysis, HotOTC and FeedBlitz reported earlier on Lightwave Logic (LWLG), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Lightwave Logic Inc. (NASDAQ: LWLG) is a development stage firm that is engaged in developing photonic devices and non-linear optical polymer materials systems for fiber-optic data communications and optical computing markets.

The firm has its headquarters in Englewood, Colorado and was incorporated in 1997, on June 24th. Prior to its name change in March 2008, the firm was known as Third-Order Nanotechnologies Inc. It operates as part of the specialty chemicals industry, under the basic materials sector. The firm serves consumers in the United States.

The enterprise is involved in designing and synthesizing organic chromophores for use in its electro-optic polymer systems and photonic device designs. It also provides electro-optic modulators, which convert data from electric signals to optical signals for transmission over fiber-optic cables; and the ridge waveguide modulator, a modulator that fabricates the waveguide within a layer of its electro-optic polymer system. In addition to this, the enterprise also offers the polymer photonic integrated circuits, a photonic device, which integrates various photonic functions on a single chip. It focuses on selling its products to electro-optic device manufacturers, such as networking and switching suppliers, telecommunications component and systems manufacturers, semiconductor companies, computing firms, Web 2.0 media, aerospace firms and government agencies.

The company, which recently released its latest financial results, remains focused on strengthening its portfolio and securing new licensing agreements. This will open the company up to new growth and investment opportunities while also generating additional revenues.

Lightwave Logic (LWLG), closed Thursday's trading session at $3.42, up 9.6154%, on 1,584,237 volume. The average volume for the last 3 months is 7.859M and the stock's 52-week low/high is $2.435/$9.05.

Cipher Mining (CIFR)

MarketClub Analysis, MarketBeat, StockEarnings, Schaeffer's, TradersPro, The Online Investor, smartmoneytrading, QualityStocks, Money Wealth Matters, INO Market Report and Early Bird reported earlier on Cipher Mining (CIFR), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Cipher Mining Inc. (NASDAQ: CIFR) is a Bitcoin mining firm that is engaged in developing and operating cryptocurrency mining businesses.

The firm has its headquarters in Rye, New York and was incorporated in 2021. Prior to its name change, the firm was known as Good Works Acquisition Corp. It operates as part of the financial activities industry. The firm serves consumers around the globe.

The company’s objective is to be the leading mining firm for Bitcoin in the U.S. through its dedicated and seasoned senior management team. Its mission is to offer the important foundation needed for the Bitcoin network to flourish. The company intends to do so through market-leading power purchase arrangements and the use of the best-in-class technology, which will enable it to become a market leader in cryptocurrency mining.

The enterprise is focused on strengthening and expanding the critical infrastructure of Bitcoin’s network in the United States. It offers financial services, which include Bitcoin mining services.

The company, which has entered into a number of low-cost power purchase agreements as well as machine contracts for about 142,000 Bitcoin mining rigs which can generate a hash rate of up to 19.5 EH/s, plans to strengthen its Bitcoin critical network infrastructure by building out a significant Bitcoin mining footprint in the U.S. This footprint will help market the company and its services, which will bring in more investments into the company and grow its reach. This will in turn grow its revenues and boost its growth, which will benefit its stakeholders.

Cipher Mining (CIFR), closed Thursday's trading session at $4.99, up 9.1904%, on 18,311,094 volume. The average volume for the last 3 months is 257,104 and the stock's 52-week low/high is $2.155/$5.75.

Antelope Enterprise Holdings (AEHL)

TradersPro, QualityStocks, MarketClub Analysis, The Online Investor, Small Caps and ProTrader reported earlier on Antelope Enterprise Holdings (AEHL), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Antelope Enterprise Holdings Ltd (NASDAQ: AEHL) is a diversified firm that is focused on selling and manufacturing ceramic tiles for designing commercial and residential buildings’ interior flooring and exterior siding in China.

The firm has its headquarters in Jinjiang, the People’s Republic of China and was incorporated in 1993, on September 30th by Jia Dong Huan. Prior to its name change in October 2020, the firm was known as China Ceramics Co. Ltd. It operates in the materials sector, under the chemicals sub-industry.

The enterprise sells its products under the WULIQIAO, TOERTO, Pottery Capital of Tang Dynasty, Hengdeli, HDL, Hengda and HD brands directly to property developers as well as via a network of distributors.

The company provides its products in the following categories: polished glazed tiles, ultra-thin tiles, rustic tiles, glazed porcelain tiles, glazed tiles and porcelain tiles. Its tiles are available in more than 2000 size combinations, colors and styles. They are used on exterior siding, on interior walls for decorative purposes and for flooring. Its manufacturing facilities are located in Gaoan, in the province of Jiangxi and in Jinjiang, in the province of Fujian. In addition to this, the company’s subsidiary Antelope Holdings Co. Ltd (Chengdu), offers fintech solutions which include developing blockchain software.

The firm recently released its financial results for the fiscal year 2020, with its CEO noting that the company was focused on extending its reach in the larger Southeast Asia market outside China and had a strategy to grow its building materials sector, which would capitalize on new building construction.

Antelope Enterprise Holdings (AEHL), closed Thursday's trading session at $1.99, up 8.7432%, on 134,160 volume. The average volume for the last 3 months is 37,865 and the stock's 52-week low/high is $1.22/$9.50.

Orion Energy Systems (OESX)

SmarTrend Newsletters, Wall Street Resources, InvestorPlace, TradersPro, MarketBeat, The Wealth Report, StreetInsider, StockMarketWatch, Zacks, Daily Trade Alert, PennyToBuck, Cabot Wealth, Trades Of The Day, Marketbeat.com, CRWEWallStreet, DrStockPick, CRWEPicks, PennyOmega, Stock News Now, StockHotTips, QualityStocks, CRWEFinance, The Street, BestOtc, TopPennyStockMovers, TraderPower, StockEarnings, FreeRealTime, Louis Navellier, PoliticsAndMyPortfolio, Alternative Energy, SmallCapVoice, StocksEarning, The Online Investor, Top Pros' Top Picks and SmallCap Network reported earlier on Orion Energy Systems (OESX), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Orion Energy Systems Inc. (NASDAQ: OESX) (FRA: 5A4) is focused on designing, developing, manufacturing, marketing, selling, installing and implementing energy management systems for exterior area lighting, industrial, commercial office and retail applications.

The firm has its headquarters in Manitowoc, Wisconsin and was incorporated in 1996. It serves consumers in North America.

The company operates through the distribution services, engineered systems and U.S. market segments. The U.S. market segment is involved in the production and sale of energy management and commercial lighting systems to wholesale contractors while the engineered segment offers engineering and construction services for energy management and commercial lighting systems. This segment is also involved in the development and sale of lighting products. On the other hand, the distribution segment is engaged in marketing lighting products to distributors and agencies.

The enterprise’s products include smart building control systems which offer data intelligence capabilities and lighting control options for building managers; and LED and HIF fixtures for energy and lighting management needs, which includes fixtures for parking lots, retail, agribusinesses, outdoor applications, roadways, mezzanine and private label resale. It also offers lighting-related energy management services, which include engineering design, installation and recycling. The enterprise serves its consumers through independent sales agencies and distributors, energy service firms and electrical contractors, as well as directly.

The company recently acquired Stay-Lite Lighting, a major electrical maintenance and lighting service provider. This acquisition will accelerate the growth of its maintenance service business while extending its consumer reach into new regions, which will bring in additional revenue as well as new investors into the company.

Orion Energy Systems (OESX), closed Thursday's trading session at $1.15, up 8.5008%, on 108,541 volume. The average volume for the last 3 months is 15,177 and the stock's 52-week low/high is $0.8139/$1.90.

Regis Corporation (RGS)

Streetwise Reports, Daily Markets, QualityStocks, MarketBeat, Zacks, Marketbeat.com, StreetInsider, Market Intelligence Center Alert, InvestorPlace, FreeRealTime, Early Bird, SmarTrend Newsletters, DrStockPick, StockMarketWatch, The Online Investor, CRWEPicks, CRWEFinance, Investor Guide, BUYINS.NET, BestOtc, CRWEWallStreet, Barchart, PennyToBuck, Zeke Truligio, RedChip, SmartMoneyTrading, Stock Tips Network, StockHotTips, Street Insider, SystemTrading, The Motley Fool, Trades Of The Day, Trading Concepts and PennyOmega reported earlier on Regis Corporation (RGS), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Regis Corporation (NYSE: RGS) (FRA: RGI) is a franchisor, operator and owner of hair care and hairstyling salons around the globe.

The firm has its headquarters in Minneapolis, Minnesota and was incorporated in 1922 by Florence Kunin and Paul Kunin. It serves consumers around the globe, with a focus on Puerto Rico, Canada and the United States.

The company operates through the company-owned and franchise salon segments. It operates and franchises salons in 6 divisions, namely International, SmartStyle family hair salons, Trade Secret, MasterCuts, Strip center salons and Regis salons. Most of the company’s salons can be found in Wal-Mart stores, shopping centers and strip malls. Its salons mainly operate under the following trade names: First Choice Haircutters, Roosters, Cost Cutters, Open salon, Sassoon Saloon and Regis Salons. It derives the majority of its revenue from these locations.

The enterprise’s salons offer hair coloring, haircutting and styling services which include shampooing and conditioning. It also sells hair care and beauty products. Brands in the enterprise’s retail assortment include Moroccanoil, Kenra, Regis sexy hair concepts, Paul Mitchell and Biolage. It also provides an OpenSalon mobile app and a back-office salon management system known as OpenSalon Pro. In addition to this, the enterprise operates accredited cosmetology schools. It maintains ownership interests in the MY Style concepts in Japan and Empire Education Group in the United States.

The company recently announced its latest financial results, with its CEO noting that the firm was focused on increasing sales and driving its growth. Its growth will help encourage more investments into the firm.

Regis Corporation (RGS), closed Thursday's trading session at $4.9, up 7.6923%, on 29,885 volume. The average volume for the last 3 months is 35,515 and the stock's 52-week low/high is $3.8681/$28.004.

TCTM Kids IT Education (TCTM)

We reported earlier on TCTM Kids IT Education (TCTM), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

TCTM Kids IT Education Inc. (NASDAQ: TCTM) (FRA: 0T8B) is a holding firm focused on providing Science, Technology, Engineering, Arts, Mathematics (STEAM) and information technology (IT) education courses.

The firm has its headquarters in Beijing, China and was incorporated in September 2002 by Shao Yun Han. Prior to its name change in February 2024, the firm was known as Tarena International Inc. It operates as part of the education and training services industry, under the consumer defensive sector. The firm mainly serves students in the People’s Republic of China.

The company operates through the Kid Training and Adult Training segments. The Kid Training segment provides K-12 education programs. On the other hand, the Adult Training segment offers students an education platform which combines live distance instruction, classroom-based tutoring and online learning modules.

The enterprise, through its innovative education platform, offers supplementary science, technology, engineering, and mathematics (STEM) education programs to young children aged between 3 and 18 through online teaching models and instructors from online or offline learning centers. It also operates an education platform that offers distance instruction, classroom-based learning, and online learning modules. In addition to this, the enterprise operates 61it.cn, an online platform to facilitate the live instruction of STEM education courses; and Tongcheng Online App.

The firm, which recently changed its name, is focused on encouraging kids to lean code, developing their logical thinking and learning abilities, and allowing them to discover their potential and interests. This will greatly benefit their students while also encouraging additional investments into the firm.

TCTM Kids IT Education (TCTM), closed Thursday's trading session at $1.16, off by 5.6911%, on 8,532 volume. The average volume for the last 3 months is 424,088 and the stock's 52-week low/high is $0.75/$4.02.

FSD Pharma Inc. (HUGE)

QualityStocks, Schaeffer's, BioMedWire, BUYINS.NET, PsychedelicNewsWire, StockMarketWatch, MarketClub Analysis, Broad Street, bullseyeoptiontrading, CFN Media Group, AwesomeStocks, InvestorPlace, StockWireNews, Penny Dreamers, StockEarnings and Fierce Analyst reported earlier on FSD Pharma Inc. (HUGE), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

FSD Pharma (NASDAQ: HUGE) (CSE: HUGE) (FRA:0K9A), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions, has entered into an exclusive option agreement with the University of Southern California (“USC”). Signed June 11, 2024, the option agreement allows FSD Pharma to exclusively evaluate, for an initial term of six months, a novel dietary supplement technology for commercialization. At the end of this term, the company will have the option to either extend it for a further six months or to sign an exclusive license with USC for the technology. The company is evaluating this novel technology for the potential to further increase the effectiveness of certain ingredients currently present in unbuzzd(TM). Launching this summer, unbuzzd(TM) is a scientifically formulated blend of vitamins, minerals, and herbs. It is engineered to increase alcohol metabolism, enable faster recovery from alcohol consumption, and simultaneously improve mental alertness. “We are thrilled to sign the option agreement with USC. We are looking forward to evaluating this novel technology that has the potential to both further enhance the effectiveness of unbuzzd(TM) and increase our target market by enabling the development of new products,” said Zeeshan Saeed, Founder, CEO and Executive Co-Chairman at FSD Pharma, in the press release.

To view the full press release, visit https://ibn.fm/gcrdJ

About FSD Pharma Inc.

FSD is a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Through its wholly owned subsidiary, Lucid Psycheceuticals Inc. (“Lucid”), FSD is focused on the research and development of its lead compound, Lucid-MS (formerly “Lucid-21-302”). Lucid-MS is a patented new chemical entity shown to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis, in preclinical models. FSD has also licensed unbuzzed(TM), a proprietary formulation of natural ingredients, vitamins and minerals to help with liver and brain function for the purposes of quickly relieving individuals from the effects of alcohol consumption for use in the consumer recreational sector, to Celly Nutrition Corp. (“Celly Nu”) and is entitled to a royalty on the revenue generated by Celly Nu from sales of products created using the technology rights granted under the licensing agreement. FSD continues its R&D activities to develop novel formulations for alcohol misuse disorders and continues the development of such treatments for use in the healthcare sector. FSD maintains a portfolio of strategic investments through its wholly owned subsidiary, FSD Strategic Investments Inc., which represent loans secured by residential or commercial property. For more information, visit the company’s website at www.FSDPharma.com.

FSD Pharma Inc. (HUGE), closed Thursday's trading session at $0.2151, off by 9.9246%, on 960,870 volume. The average volume for the last 3 months is 21,758 and the stock's 52-week low/high is $0.2078/$1.6799.

The QualityStocks Company Corner

Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI)

The QualityStocks Daily Newsletter would like to spotlight Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI).

Scinai Immunotherapeutics (NASDAQ: SCNI), a biopharmaceutical company focused on the development of inflammation and immunology ("I&I") biological products and on providing contract development and manufacturing organization ("CDMO") services through its Scinai Bioservices business unit, has received a nonbinding letter of intent ("LOI") from the European Investment Bank ("EIB"). According to the announcement, the LOI contains terms for converting EIB's loan of approximately $27.6 million into equity in the form of prefunded warrants; the warrants, which will be exercisable into American Depositary Shares ("ADSs"), represent 19.5% of the fully diluted capital of the company as well as capped variable return mostly in the form of a royalty on the company's revenues. "The company believes that this loan-to-equity conversion would immediately eliminate the shareholders' deficit of $4.5 million and create an estimated shareholders equity surplus of approximately $14.5 million," stated the press release. "The company retained Deloitte to prepare a white paper analyzing the accounting impact of the loan-to-equity conversion. The accounting analysis is expected to be reflected in the company's Q3 2024 financial reports. . . . The company believes that these terms are very favorable to the company and its shareholders, and that the substantial reduction in its long-term liabilities should improve its standing in the financial community."

To view the full press release, visit https://ibn.fm/V1Le9

Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) is a biotechnology company focused on developing, manufacturing, and commercializing innovative immunotherapeutic products primarily for the treatment of infectious diseases and autoimmune diseases.

In collaboration with the prestigious Max Planck Institute for Multidisciplinary Sciences (MPG) and the University Medical Center Göttingen (UMG), both in Germany, Scinai is developing a pipeline of innovative nanosized antibody (NanoAb) therapies addressing diseases underserved by current treatments and with large and growing markets, such as COVID-19, asthma and psoriasis.

NanoAbs, also known as VHH-antibodies or Nanobodies, are alpaca-derived nanosized antibodies that exhibit multiple significant competitive advantages over existing antibody therapies, including stability at high temperatures, superior binding affinity, more effective and convenient routes of administration and efficient production. Scinai is uniquely positioned to advance nanosized antibody innovation from R&D through commercialization.

The company’s highly experienced and successful pharmaceutical industry leadership team includes former senior executives from Novartis, GSK and Bristol-Myers Squibb.

Since its founding, Scinai has executed eight clinical trials, including a seven-country, 12,400-participant Phase 3 trial of a prior influenza vaccine candidate, and it built, owns and operates a 20,000 sq. ft. state-of-the-art GMP biologics manufacturing facility housing its laboratories, production facilities and offices.

Lead Candidate: Inhaled COVID-19 NanoAb

In December 2021, Scinai signed definitive agreements with the Max Planck Society – parent organization of the Max Planck Institute for Multidisciplinary Sciences– and the UMG to enter a strategic collaboration for the development and commercialization of innovative COVID-19 NanoAbs.

The company is planning a rapid development path that leverages its expertise and capabilities in biological drug development and manufacturing. Scinai anticipates preclinical proof-of-concept results for an inhaled COVID-19 NanoAb by the end of 2022, with initial Phase 1/2a human clinical trial results expected in 2023.

The intended inhaled mechanism of delivery of Scinai’s COVID-19 NanoAb formulation may serve as a significant differentiator when compared to approved monoclonal antibodies, which are injected. Inhaled delivery has shown to be cheaper, more convenient and likely safer for patients and providers.

NanoAb Pipeline: Psoriasis, Asthma and More

The COVID-19 NanoAb development agreement is part of a broader five-year research collaboration agreement signed in March 2022 covering discovery, development and commercialization of NanoAbs for several other disease indications with large market medical needs, including asthma, psoriasis, macular degeneration and psoriatic arthritis.

Scinai has an exclusive worldwide license for development and commercialization of COVID-19 NanoAbs and exclusive options for similar worldwide licenses for NanoAbs for the above mentioned additional large market disorders currently underserved by approved therapeutic antibodies.

Academic research teams from MPG and UMG have verified strong affinity by the new NanoAbs to their biological target molecules and high thermostability. They have also demonstrated strong neutralization by several NanoAb candidates of their respective target molecules. Neutralization studies of the other NanoAbs are expected to begin later in 2022.

Based on the promising results, Scinai will focus development efforts beginning with the following NanoAbs:

  • NanoAbs targeting IL-17 as drug candidates for the potential treatment of psoriasis and psoriatic arthritis
  • NanoAbs targeting IL-13 and NanoAbs targeting TSLP as drug candidates for the potential treatment of asthma

These are conditions for which the antibody target is validated by existing treatments and the mechanism of action is well understood. Both represent large medical needs and growing markets. Scinai anticipates preclinical proof-of-concept for at least one of these NanoAbs in 2023. This is in addition to the aforementioned human clinical Phase 1/2a for the inhaled COVID-19 NanoAb therapy, which is also anticipated in 2023.

CDMO Services

While NanoAb pipeline development is Scinai’s core focus, the company also offers its cGMP manufacturing facility, aseptic fill and finish suite, laboratories and experienced professionals for contract development and manufacturing organization (CDMO) services. This offering is designed to keep the Scinai team abreast of the latest industry developments and trends while building experience and generating revenue to support the company’s NanoAb pipeline development.

Market Opportunity

COVID-19 treatment, target of the company’s lead NanoAb therapy candidate, had an estimated market size of $22 billion in 2021.

Future Scinai drug candidates will target conditions with large markets growing at attractive CAGRs.

The global asthma treatment market was valued at $18.08 billion in 2019 and is projected to reach $26.01 billion by 2027, exhibiting a CAGR of 4.5% during the forecast period, according to Fortune Business Insights. The research firm predicts that the global psoriasis treatment market will grow from $26.37 billion in 2022 to $47.24 billion by 2029, exhibiting a CAGR of 8.7% over the forecast period.

Management Team

Amir Reichman is Scinai’s CEO. He previously was Head of Global Vaccines Engineering Core Technologies at GSK Vaccines in Belgium. Prior to that, he held leadership roles at Novartis Vaccines’ Global Vaccines Supply Chain Management organization. He was the first employee of NeuroDerm Ltd., a company focused on transdermal drug delivery, and served as Senior Scientist until his departure in 2009. He earned a M.Sc. in Biotechnology Engineering from Ben-Gurion University and an MBA in Finance and Health Care Management from the University of Pennsylvania’s Wharton School.

Tamar Ben-Yedidia, Ph.D., is Chief Science Officer at Scinai. She has more than 30 years of experience in immunology, with specific expertise in the development of vaccines. She began her career with Biotechnology General Ltd., working on development of a recombinant Hepatitis-B vaccine. She later joined the Weizmann Institute of Science, working on the design of a peptide-based vaccine against several pathogens. She is widely published, with numerous refereed articles and invited reviews in various scientific journals. She received her Ph.D. from the Weizmann Institute.

Elad Mark is COO at Scinai. He has over 15 years of biotechnology industry experience encompassing diverse project stages including feasibility studies, conceptual and detailed design, commissioning, qualification and process validation. Prior to joining Scinai, he led Novartis’s $800 million investment in a biologics facility in Singapore. With Biopharmax and Antero, both global pharmaceutical engineering companies, he successfully led projects in Israel, China and Singapore. He holds a BSc. in Engineering from the Afeka Tel Aviv Academic College of Engineering and an MBA from the Open University of Israel.

Uri Ben-Or is CFO at Scinai. He has served as CFO with public life science companies traded on the TASE, OTC and Nasdaq. Ben-Or provides his services to Scinai through CFO Direct, a company he founded and for which he serves as CEO. He served as the VP of Finance of Glycominds, a leading biotechnology company, and as CFO of a spin-off from Telrad Networks. He also served as a Corporate Controller at Menorah Capital Markets and as an Auditor at PWC. He holds a B.A. in Business from the College of Administration, an MBA from Bar-Ilan University, and is a CPA.

Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI), closed Thursday's trading session at $2.82, up 4.8327%, on 198,283 volume. The average volume for the last 3 months is 2.302M and the stock's 52-week low/high is $2.23/$18.703.

Recent News

PaxMedica Inc. (NASDAQ: PXMD)

The QualityStocks Daily Newsletter would like to spotlight PaxMedica Inc. (NASDAQ: PXMD).

PaxMedica (NASDAQ: PXMD), a biopharmaceutical company focused on advancing treatments for neurological disorders, recently completed its three registration/validation batches of PAX-101, an IV formulation of suramin. "This accomplishment marks a significant step toward submitting a New Drug Application (‘NDA') to the U.S. Food and Drug Administration (‘FDA') in the fourth quarter of 2024. This step paves the way for potential commercial availability in the U.S. of suramin, the sole form for treating stage 1 Human African Trypanosomiasis (‘HAT') caused by Trypanosoma brucei rhodesiense. This disease, fatal and neglected, represents a critical healthcare challenge," a recent article reads. "This completion of our registration/validation batches is a crucial step as we prepare for an NDA submission for PAX-101. It marks a significant milestone in our ongoing effort," said Howard Weisman, chair and CEO of PaxMedica. "This manufacturing achievement has significantly aided in overcoming one of the major barriers to initiating further tests on PAX-101 for addressing the core symptoms of autism spectrum disorder (‘ASD'), which remain under investigation. The progress we've made brings us closer to our objective of becoming a reliable global supplier of suramin, particularly for treating Stage 1 HAT, a condition for which suramin is recognized as one of the world's essential medicines."

To view the full article, visit https://ibn.fm/lZs9m

PaxMedica Inc. (NASDAQ: PXMD) is a clinical stage biopharmaceutical company focusing on the development of novel anti-purinergic therapies (APTs) for the treatment of Autism Spectrum Disorder (ASD) and other serious conditions with intractable neurologic symptoms.

The company’s lead programs are focused on ASD, for which there are currently no approved pharmacologic treatments that target its cause and symptoms. Currently used treatments only address the symptoms of the condition, rather than targeting the pathophysiology itself.

PaxMedica is on a promising path to address these unmet medical needs, bringing hope to millions. Anti-purinergic therapies target the excess production of purines in cells. An overexpression of purines can offset homeostasis and result in an overproduction of cellular adenosine triphosphate, the main energy molecule in all living cells.

The company is headquartered in Tarrytown, New York.

Product Pipeline

PaxMedica is building a robust pipeline of products targeting ASD and related neurodevelopmental conditions. The company’s lead product in development may help eliminate, reduce or modulate some of the more troublesome aspects of ASD. That would open the potential for people with autism to integrate their behavior with others more successfully and improve their lives.

PaxMedica’s lead programs, PAX-101 and PAX-102, utilize the company’s proprietary source of suramin sodium, a broadly acting anti-purinergic therapy that has been known for over 100 years. Its current pipeline includes:

  • PAX-101 (IV Suramin) for ASD – PAX-101 completed a Phase 2B study for ASD in 2021. Suramin is a broadly acting APT and has reported positive results from a dose range study. The results of PaxMedica’s Phase 2B study, which targeted 52 subjects across six sites in South Africa, were presented to AACAP in October 2021.
  • PAX-102 (Intranasal Suramin) – PaxMedica has developed a proprietary intranasal formulation of suramin that is currently being evaluated in ASD and other neurodevelopmental conditions.
  • PAX-101 for HAT – Given suramin’s historical use as a treatment for Human African Trypanosomiasis (HAT), or African Sleeping Sickness, the company is also developing PAX-101 as a treatment for HAT. PaxMedica’s most advanced program is the pursuit of PAX-101 for early-stage East African HAT.
  • Selective APTs – PaxMedica has conducted several preclinical studies to evaluate other APTs that are more selective to specific purinergic receptors and may offer additional benefits over suramin.

Market Opportunity

According to a report by Fortune Business Insights, a leading global market research company, the global ASD therapeutics market was estimated at $1.93 billion in 2022 and is projected to grow from $2.01 billion in 2023 to $3.42 billion by 2030, a CAGR of 7.9% over the forecast period. As there is no current treatment for the core symptoms of autism, PaxMedica believes the addressable market for PAX-101, if approved, could greatly exceed these forecasts.

Autistic disorder, Asperger’s Syndrome and Pervasive Development Disorder are the three main types of ASD, affecting millions of people globally. A 2020 report by the U.S. Centers for Disease Control & Prevention estimated that one in 36 children in the U.S. have been diagnosed with autism disorder.

Several factors are expected to contribute to market growth prospects. A growing prevalence of the condition globally and rising awareness coupled with available treatment options are key factors expected to drive ASD therapeutics market growth during the forecast period. Growing investment in R&D to find effective treatments is also expected to fuel global market growth.

Management Team

Howard Weisman is Chairman and CEO of PaxMedica. He has been a founder and CEO of several specialty pharma and medical device companies. Most recently, he was executive chairman and co-founder of Sofregen, a biotech company. He also served as CEO and president of Seventh Sense Biosystems, a medical device development company. He also was founder, chairman and CEO of EKR Therapeutics, a specialty pharmaceutical company, and founder and COO of ESP Pharma, a company focused on cardio and neurovascular products. He has a bachelor’s degree in chemistry from Rutgers University.

David Hough, M.D., is Chief Medical Officer at PaxMedica. He is a neuroscience clinical development consultant who previously served as vice president at Janssen Research and Development and in various leadership roles over 17 years. Most recently, he was the compound development team leader for SPRAVATO® for treatment-resistant depression. Prior to that, he was the schizophrenia disease area leader. He played a pivotal role in the development programs for oral INVEGA®, INVEGA SUSTENNA® and XEPLION® for schizophrenia. He is a graduate of West Point and is board certified in psychiatry.

Stephen Sheldon is COO and CFO at PaxMedica. He has served as CEO of Thailand-based specialty healthcare company Indochina Healthcare Co. Ltd. since 2015. Previously, he was a consultant for PricewaterhouseCoopers Healthcare Advisory in the Chicago office. He was responsible for developing specialty pharmacy patient programs, strategy development for specialty products and compliance programs. He has an MBA from Thunderbird School of Global Management and a bachelor’s degree in computer science and visual arts from Bowdoin College.

PaxMedica Inc. (NASDAQ: PXMD), closed Thursday's trading session at $0.28219, up 4.4181%, on 10,543 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $18.703/$.

Recent News

SuperCom Ltd. (NASDAQ: SPCB)

The QualityStocks Daily Newsletter would like to spotlight SuperCom Ltd. (NASDAQ: SPCB) .

SuperCom Ltd. (NASDAQ: SPCB) is a digital security solutions innovator focused on the market for monitoring criminal offenders and tracking for public security. "Electronic-monitoring security solutions developer SuperCom is devoted to using technology to limit the threat of stalking-related violence by working with criminal justice systems, consumers and government-level security experts, and providing effective monitoring, offender tracking and rehabilitation reinforcement programs to promote public safety. The company is currently employing its innovative PureOne solution to deliver an all-in-one field-proven RFID and mobile technology and product suite that is growing with the addition of GPS technologies," a recent article reads. "Our partnership's expansion into GPS technology with our PureOne devices marks a notable achievement for SuperCom," SuperCom CEO and President Ordan Trabelsi is quoted as saying. "This project exemplifies our dedication to delivering cutting-edge technology and reinforces our position as a leader in the electronic monitoring industry."

To view the full article, visit https://ibn.fm/8MtdH

SuperCom Ltd. (NASDAQ: SPCB) provides secured solutions for the e-government, IoT and cybersecurity sectors. Since 1988, the company has been a trusted global provider of traditional and digital identity offerings, providing cutting-edge electronic and digital security solutions to governments and organizations, both private and public, around the world.

SuperCom’s mission is to revolutionize the public safety sector worldwide through proprietary electronic monitoring technology, data intelligence, and complementary services.

The company is headquartered in Tel Aviv, Israel, with offices in California and other regions in the U.S.

Business Units

IoT and Connectivity

SuperCom IoT products and solutions provide advanced electronic monitoring solutions and services to criminal justice agencies, enabling customers to detect unauthorized movement of people, vehicles, and other monitored objects. The company provides an all-in-one, field-proven PureSecurity offender monitoring suite, accompanied by services such as GPS monitoring, home detention, domestic violence prevention, and more. The company’s services are specifically tailored to meet each client’s needs.

SuperCom’s proprietary Puresecurity suite of hardware, connectivity, and software components is the foundation for its criminal justice services and offerings. SuperCom is leveraging its extensive technology expertise to implement groundbreaking artificial intelligence (AI) technologies into various parts of its core offerings. By leveraging the power of AI, SuperCom’s PureSecurity platform can offer new abilities, such as amplified data analysis, predictive modeling, and streamlined automation – all geared toward optimizing decision-making and operational efficiency.

Competitive advantages of SuperCom’s technology include:

  • Long Battery Life (No Tag Charging Required)
  • Ultra Lightweight Form Factor
  • Next-Gen Location Tech
  • Protection of Domestic Violence Victims
  • And More

 

Cybersecurity

In 2015, SuperCom identified the cybersecurity market as a fast-growing space with significant advantages due to synergistic technologies and a shared customer base with its e-Gov and IoT business units. Consequently, SuperCom strategically acquired Prevision Ltd., a company with a strong presence in the market and a broad range of competitive cybersecurity services.

During the first quarter of 2016, SuperCom acquired Safend Ltd., an international provider of cutting-edge endpoint data protection guarding against corporate data loss and theft through content discovery and inspection, encryption methodologies, and comprehensive device and port control.

Both acquisitions significantly expanded the breadth of the company’s global cybersecurity capabilities.

e-Gov

Through proprietary e-government platforms and innovative solutions for traditional and biometrics enrollment, personalization, issuance, and border control services, SuperCom has helped governments, and national agencies design and issue secured multi-identification, or Multi-ID, documents and robust digital identity solutions to their citizens, visitors, and lands.

The company has focused on expanding its activities in the traditional identification, or ID, and electronic identification, or e-Gov, markets, including the design, development, and marketing of identification technologies and solutions to governments in Europe, Asia, America, and Africa using SuperCom’s e-Government platforms.

Market Opportunity

Data from Berg Insight estimates the market for electronic monitoring solutions will grow from $1.2 billion in 2021 to $2.1 billion in 2026, marking a CAGR of 10.8% for the forecast period.

High recidivism rates, prison overcrowding, and soaring incarceration costs are some factors that are driving the electronic monitoring of offenders’ market growth.

An analysis by ReportLinker forecasts that the global cybersecurity market will grow from an estimated value of $173.5 billion in 2022 to $266.2 billion by 2027, achieving a CAGR of 8.9% for the period.

The increased number of data breaches worldwide, the ability of malicious actors to operate from anywhere in the world, the links between cyberspace and physical systems, and the difficulty of reducing vulnerabilities and consequences in complex cyber networks are some factors driving the cybersecurity market growth.

Management Team

Ordan Trabelsi is President and CEO of SuperCom. He has over 15 years of experience as CEO, growing high-tech companies globally. He also has experience in research and development and product innovation, as well as hands-on experience in cybersecurity, encryption, advanced mathematics, and mobile and internet network technologies. Prior to joining SuperCom, he served as co-founder and CEO of Klikot Inc., a global social networking company. He holds an MBA from Columbia University and a B.Sc. in Computer Engineering from The Technion: Israel Institute of Technology.

Barak Trabelsi is COO of SuperCom. He has expertise in big data, cyber, mobile, and internet network technologies, as well as extensive experience in product development and strategies. Prior to joining SuperCom, he served as Senior Product Manager at Equinox Ltd. Before that, he served for four years as VP of R&D at Sigma Wave, a wireless, security, and internet-focused company. He holds a B.Sc. in Computer Science and Business, as well as an MBA from Tel Aviv University.

Gil Alfi is VP of Sales at Safend Ltd., SuperCom’s cybersecurity subsidiary. He joined SuperCom in 2016 as VP of Business Development for Safend. He has more than 18 years of experience in technology companies. He served as an R&D team technology lead for more than seven years and as Director of Product Management for various telecom and wireless companies for more than 10 years. Prior to joining SuperCom, he served as Regional Sales Director at Safend, managing sales regions in Europe and Africa. He holds a B.Sc. in Computer Science and Mathematics and an M.Sc. in Computer Science from Bar-Ilan University.

SuperCom Ltd. (NASDAQ: SPCB), closed Thursday's trading session at $0.1948, up 1.9362%, on 1,467,546 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.1524/$1.27.

Recent News

ECGI Holdings Inc. (OTC: ECGI)

The QualityStocks Daily Newsletter would like to spotlight ECGI Holdings Inc. (OTC: ECGI).

ECGI Holdings (OTC: ECGI), a diversified holding company with a unique portfolio in viticulture and luxury fashion, is announcing the signing of a binding Letter of Intent ("LOI") to acquire all outstanding shares of Pacific Saddlery, Inc., a renowned manufacturer and retailer of luxury equestrian tack, apparel and accessories, in exchange for $5,000,000 in ECGI-restricted shares. According to the announcement, these shares will remain restricted until ECGI uplists to a national exchange. The acquisition aligns with ECGI's objectives of expanding its presence in the luxury brands sector. It is expected to generate new recurring revenue streams and enhance ECGI's position in the luxury equestrian market. The announcement noted that Nick Collins, a well-known professional in the equestrian luxury market, will take up the role of president of ECGI, with Jamie Steigerwald, CEO of ECGI, assuming the additional role of president of Pacific Saddlery. Together, they will serve as co-chairmen of ECGI. "We are thrilled to finalize this acquisition and further our commitment to building high-quality, luxury brands," commented Steigerwald. "Nick Collins brings unparalleled experience and a deep understanding of the equestrian luxury market, which will be invaluable as we integrate Pacific Saddlery into our portfolio. "

To view the full press release, visit https://ibn.fm/KSy6y

ECGI Holdings Inc. (OTC: ECGI) is a diversified holding company with a distinctive portfolio encompassing viticulture and luxury fashion. The company owns and manages a five-acre vineyard in Lake County, California, specializing in cultivating the Petite Sirah varietal, known for its bold and rich character, aligning with the growing demand for unique and high-quality wine experiences.

In the fashion sector, ECGI has strategically invested in Pacific Saddlery, a premier manufacturer and retailer of luxury equestrian tack, apparel and accessories. This unique blend of wine and fashion investments reflects ECGI Holdings’ commitment to delivering sophistication and innovation across diverse markets, positioning the company as a distinctive player in the intersection of technology, viticulture and luxury lifestyle.

Moving forward, ECGI Holdings is focused on identifying and capitalizing on growth opportunities that align with the company’s business objectives and continuing to improve its financial structure. In 2024, ECGI Holdings was approved by Evolve — a distinguished name in vacation rental management. This partnership will transform the company’s 40-acre Lake County property into a luxurious short-term rental destination aptly named Vintner’s Caldera Ranch.

ECGI Holdings is excited about the possibilities that Vintner’s Caldera Ranch creates for shareholders and looks forward to further developments poised to unlock the value of other underutilized assets. The company believes that it is laying a solid foundation for sustained success and profitability in the years to come.

ECGI Holdings is headquartered in Irvine, California.

Operational Philosophy

ECGI Holdings has embarked on an ambitious new vision and strategic direction to build and nurture luxury brands that resonate with its core values and market aspirations. Its joint venture with Pacific Saddlery epitomizes ECGI Holdings’ strategic shift toward luxury branding, leveraging Pacific Saddlery’s tangible and established market presence in equestrian products.

This transition will also allow ECGI Holdings to explore new pathways to monetize its underutilized assets, including the company’s vineyard. A key highlight of the company’s future outlook is the debut of Pacific Saddlery’s new mobile retail boutique at specific equestrian events in 2024. This innovative venture represents a significant step in ECGI Holdings’ strategy to enhance brand visibility and engage directly with the company’s target market.

In addition, the Vintner’s Caldera Ranch development marks a significant step in advancing the company’s strategy to revitalize and leverage underutilized assets. Vintner’s Caldera Ranch is set against the backdrop of Lake County’s breathtaking scenery, offering an exclusive getaway experience that blends natural beauty with luxury. Choosing Evolve is a strategic move to ensure that Vintner’s Caldera Ranch not only meets but exceeds the high standards of service that luxury guests expect.

Evolve’s expertise in maximizing rental potential and delivering exceptional guest experiences is crucial to the company’s vision of making Vintner’s Caldera Ranch a preferred choice for discerning travelers. With this venture, ECGI Holdings is not only expanding its footprint within the luxury rental marketplace, but also contributing to the local economy and enhancing the appeal of Lake County as a tourist destination.

The company’s focus remains steadfast on strategic growth, operational excellence and customer satisfaction.

Market Outlook

A report from Grand View Research, a global market research and consulting company, estimated the value of the worldwide luxury brands market at $366.23 billion in 2023 and projects the market to grow to a value of $580.43 billion by 2030, achieving a CAGR of 6.8% over the forecast period.

Rising disposable income and wealth in various regions of the world, particularly in emerging markets such as China and India, have propelled the growth of the market, according to the report.

Younger consumers, such as millennials and Generation Z, are increasingly entering the luxury market, driving demand for more contemporary and experiential luxury offerings. The rise of social media and influencer marketing has greatly impacted the visibility and desirability of luxury products, the report states.

Management Team

Jamie Steigerwald is CEO of ECGI Holdings, Inc. He is a successful entrepreneur with over 30 years of experience. Most recently, he was COO of Sugarmade Inc. (OTC: SGMD), a California cannabis real estate, cultivation, manufacturing and services company. He is the owner of SwiftLead, an Orange County web marketing, design and development company. He previously was COO for First USA Home Loans, a retail mortgage lender, and co-founder and President of SwiftLead Software, a mortgage lead tracking system.

Nick Collins is CEO at Pacific Saddlery. He brings over 25 years of expertise in equestrian luxury goods. He previously founded Rolling Meadows and created the Allon Equestrian and Renard et Cheval apparel brands. He was instrumental in creating and launching Kaval.com, an online equestrian apparel and accessories site.

ECGI Holdings Inc. (OTC: ECGI), closed Thursday's trading session at $0.0023, up 4.5455%, on 5,432,622 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.0016/$0.0185.

Recent News

Horizon Fintex | Upstream

The QualityStocks Daily Newsletter would like to spotlight Horizon Fintex | Upstream

The evolution of Web3 has introduced a secure and decentralized way of interacting online. However, despite the significant advancements in blockchain technology, user interaction, accessibility, and experiences seem to be the big hurdle for Web3 applications. One of the biggest ways Web3 could improve user experience and reach its full potential is by enhancing the capabilities of functional tools. This isn't just a way to make Web3 an ideal concept for tech enthusiasts but also a tangible reality for everyone else. Currently, when accessing Web3, users are faced with various technical tools that can be overwhelming to master particularly for first-time users. As a result, users become frustrated and disconnected from the Web3 technology. On top of that, Web3 developers should consider incorporating gamification elements such as badges and rewards to help make it easier for users to enjoy learning and drive user engagement. This will also encourage users to finish onboarding tasks as well as understand more about Web3. Entities such as Horizon Fintex are taking steps to seamlessly integrate Web3 into their products, and this could help in accelerating the adoption of these technologies by everyday people.

Horizon Fintex is a software business specializing in compliant securities solutions. The company aims to facilitate the future of capital markets by leveraging the regulatory experience of Wall Street bankers and the proven track record of technology veterans to bring focus to compliance, efficiency, security and transparency.

Horizon’s flagship product is the revolutionary trading app ‘Upstream’, a MERJ Exchange Market, and the first regulated market powered by a blockchain to offer both digital securities and NFT trading. Upstream traders experience T+0 settlement, best bids and offers displayed on a transparent public orderbook that prevents predatory market practices – all from a user-friendly trading app.

Products

Horizon Fintex offers a full suite of end-to-end blockchain-enhanced software solutions to create a seamless experience for both issuers and investors. Its product suite includes:

  • Securitization & IssuanceETSware is an end-to-end Electronic Trading System streamlining capital raising from primary issuance through compliant secondary trading.
  • KYC Compliance OnboardingKYCware is a white label Know Your Customer (KYC) and Anti-Money Laundering (AML) compliance software solution offering best-in-class cryptographic security to compliantly onboard and verify user identity through a smartphone application.
  • AML Screening SoftwareAMLCop offers advanced Anti-Money Laundering (AML) software to streamline the verification of user details against a proprietary database of global sanctions, politically exposed persons (PEPs) and watchlists.
  • Cap. Table Management ToolsCustodyWare equips registered U.S. transfer agents with next-generation cap. table management software to manage securities on behalf of their clients pursuant to an SEC-registered or exempt securities offering.
  • Exchange & Trading App TechnologyOpen Order Book offers Ethereum blockchain securities exchange software to power the next generation of trading venues for digital assets.

Upstream – The Horizon-Powered Trading App

Upstream is a joint venture with MERJ Exchange (merj.exchange), an affiliate of the World Federation of Exchanges.

Upstream aims to be the premiere global trading hub offering issuers around the world exposure to a digital-first investor base that can trade using USDC digital currency along with credit, debit, PayPal, and USD (fiat) to increase liquidity and enhance price discovery; while also offering investors access to dual-listed companies, IPOs, crowdfunded companies, U.S. & Int’l. equities, digital coupons and NFTs directly from a user-friendly trading app.

Upstream aims to unlock liquidity for investors of all levels while offering industry-leading levels of transparency, accessibility and investor protections enforced using Ethereum blockchain technology.

Management Team

Brian Collins is the CEO of Horizon Fintex. He founded the company in 2010. From 1999-2010, Mr. Collins was CEO of Abbey Technology in Switzerland, specializing in the design of trading software for Swiss banks. Prior to this, he worked for Credit Suisse in Zürich, designing and building proprietary equity trading solutions. Mr. Collins graduated in 1990 with a BS in Computer Systems from the University of Limerick, Ireland.

Mark Elenowitz is the company’s President. He is a Wall Street veteran with over 29 years of experience. Mr. Elenowitz was the co-founder of a U.S. broker dealer and is Managing Director of two U.S. broker dealers, responsible for advising clients on compliance, capital structure and capital market navigation. He was responsible for leading the first successful Reg A+ IPO of a company to list on the NYSE and others which listed directly onto Nasdaq. He is a noted speaker at Small Cap and Reg A events, including the SEC Small Business Forum, and has been profiled in BusinessWeek and CNBC, as well as several other publications. Mr. Elenowitz is a graduate of the University of Maryland School of Business and Management with a BS in Finance and holds Series 24, 62, 63, 79, 82 and 99 licenses.

Dr. Andrew Le Gear is the CTO of Horizon Fintex. Prior to joining the company in 2013, he worked as a software engineer with Dell Inc. (2012-2013) and Lehman Brothers and Nomura Plc. (2007-2012). Dr. Le Gear was a co-founder of Juneberi Ltd., a research-driven software tech start-up (2004-2007). He graduated in 2006 with a Ph.D. in Computer Science from the University of Limerick, Ireland.

Peter Hall is the company’s CIO. Prior to joining Horizon Fintex in 2011, he worked at Microsoft (2008-2011), Atos Origin (2004-2008) and AIT Group Plc. (1998-2002). Mr. Hall has held CISSP certification since 2010. He graduated from the University of Sheffield, UK in 1995 and earned an MS from the University College London in 2006.

Mike Boswell is the CFO of Horizon Fintex. A Wall Street veteran, he co-founded a U.S. broker dealer and served as Chief Compliance Officer. Mr. Boswell was also Managing Director of TriPoint Capital Advisors, a merchant banking and financial consulting company, and CFO of Mission Solutions Group, a privately held defense sector firm. He earned an MBA from John Hopkins University and a BS in Mechanical Engineering from the University of Maryland. Mr. Boswell holds Series 24, 62, 63, 79, 82 and 99 licenses.

Recent News

chart

Software Effective Solutions Corp. (OTC: SFWJ)

The QualityStocks Daily Newsletter would like to spotlight Software Effective Solutions Corp. (OTC: SFWJ).

A group of senators from the Democratic Party is urging a significant committee to ensure small cannabis entities have equitable access to federal Small Business Administration (SBA) lending programs and development resources available to other industries. In an April letter to the leaders of the Appropriations subcommittee, the senators urged that the FY 2025 FSGG spending measure include provisions to stop the SBA from rejecting loan applications from small cannabis entities operating legally in states that have approved marijuana use and sales. In a news release regarding the letter and the other efforts she recently spearheaded, Rosen stressed the value of small entities to Nevada's economy. She emphasized her resolve to slash bureaucratic obstacles to facilitate such businesses' access to financing and assist them obtain the federal support they require for expansion and prosperity. Industry actors such as Software Effective Solutions Corp. (d/b/a MedCana) (OTC: SFWJ) would be glad to see that legitimate marijuana companies which need SBA services can access them just as businesses in other industries can.

Software Effective Solutions Corp. (d/b/a MedCana) (OTC: SFWJ) is a global infrastructure and holding company in the cannabis industry. MedCana currently has five companies focused on pharmaceutical cannabis production, as well a software company focused on managing processes for plant-to-patient operations. The recent acquisition of an irrigation and greenhouse technology company has rounded out MedCana’s portfolio of holdings.

MedCana’s focus is on developing clients and companies in Latin America, initially in Colombia, and partnerships with laboratories, research facilities and hospitals throughout the world. MedCana is building the technology, laboratories, growing facilities and scientific teams to provide premium pharmaceutical-grade cannabis extracts to the world.

MedCana’s goal is to be the world’s premier resource for pharmaceutical cannabis products. The company believes its advantage is its global view and reach. From initial cultivation to final product, MedCana aims to help partners produce pharmaceutical CBD and other extracts that will have no equal.

The company’s mission is to utilize its technology to partner with and develop companies that provide premium pharmaceutical-grade cannabis extracts with absolute integrity, sustainability and social responsibility. MedCana’s team of pharmaceutical scientists includes some of the most respected chemists in the world. They aim to ensure that the company’s customers and partners create premium cannabis extracts that meet the growing worldwide demand. MedCana’s software is designed to ensure traceability and quality from seed to finished product.

MedCana is headquartered in Austin, Texas, with offices in Colombia.

Production

MedCana announced in May 2023 the beginning of full-scale production of non-THC cannabis for export to Europe in response to high demand in that market. This expansion comes after the successful completion of full crop cycle testing and infrastructure development at production sites in Columbia.

The recent acquisition of the assets of Tokan Corp., a software company focused on creating an enterprise resource planning (ERP) platform for the cannabis industry, and Eko2O S.A.S., a greenhouse and irrigation engineering company, has positioned MedCana for explosive growth in the region.

As a MedCana subsidiary, Eko2O SA will increase the company’s revenue potential in Central and South America. The subsidiary specializes in the construction and distribution of greenhouses and sophisticated irrigation platforms. A positive outlook has resulted from the company’s expansion as it investigates new opportunities for greenhouse and irrigation system installations in Panama and Uruguay. These opportunities are expected to accelerate Eko2O’s development and strengthen its position as a top supplier of innovative agricultural solutions in cannabis and other sectors that are quickly moving to high technology agricultural production.

In addition, MedCana has started talks with the government in Argentina about possible incentives for beginning operations in that country as part of its ongoing worldwide development strategy. Support from the Argentinean government and the start of new operations there would greatly increase MedCana’s market share in Latin America and solidify the company’s position as the market leader in the cannabis industry.

Market Opportunity

According to a report by Grand View Research, a San Francisco-based market research and consulting company, the global cannabis extract market was valued at $3.5 billion in 2022 and is expected to expand at a CAGR of 20% from 2023 to 2030 to be worth more than $15 billion.

Growing demand for cannabis extracts, including oils and tinctures, and the increased legalization of marijuana for the treatment of different chronic ailments like arthritis, Alzheimer’s, anxiety and cancer are driving the expansion of the industry. The marijuana derivative industry is flourishing due to a greater understanding of its various medical benefits.

Management Team

Jose Gabriel Diaz is CEO of MedCana. He has successfully built, grown and sold multiple telecom companies. He was senior vice president of sales at IP Communications, a national high-speed data provider. He also founded Reallinx, a national data carrier later sold to GTT Communications. Additionally, he is currently president of the A.E.M. Business and Entrepreneurship Association in Austin, Texas.

Claudio Jiménez Cartagena, QF, Ph.D. is Chief Scientific Officer at MedCana. He joined MedCana after working with Sosteli Pharma as Technical Director and serving as a director consultant for the Corporation for Agricultural Industrial Development at the University of Antioquia in Colombia. Before that, he worked as the scientific director at the Institute of Food Science & Technology. He holds a bachelor’s degree in pharmaceutical chemistry, a master’s degree in basic biomedical sciences and a doctoral degree in Environmental Engineering from the University of Antioquia.

Julián Alberto Londoño Londoño, Ph.D., is Senior Vice President of Operations at MedCana. He previously served as general manager for the Corporation for Agricultural Industrial Development, and as Chief Scientific Officer at Sosteli Pharma in the Resource Management Department. He has developed multiple U.S. patents, and recently served as senior advisor to the Secretariat of Agriculture Development for the Government of Antioquia. He holds a doctorate in Chemical Sciences from the University of Antioquia.

Software Effective Solutions Corp. (OTC: SFWJ), closed Thursday's trading session at $0.05, even for the day, on 3 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.000001/$0.09.

Recent News

McEwen Mining Inc. (NYSE: MUX) (TSX: MUX)

The QualityStocks Daily Newsletter would like to spotlight McEwen Mining Inc. (NYSE: MUX) (TSX: MUX).

McEwen Mining (NYSE: MUX) (TSX: MUX) is an asset rich diversified gold and silver producer in the Americas with a large exposure to copper through its McEwen Copper subsidiary. The company's Chairman and Chief Owner, Rob McEwen, was featured in the latest episode of The MiningNewsWire Podcast as part of IBN's sustained effort to provide specialized content distribution via widespread syndication channels. During the interview with host Stuart Smith, McEwen discussed his extensive background in the mining sector, talked about McEwen Mining's project portfolio, and examined the mining industry's reputation relating to environmental stewardship before detailing the company's efforts to promote change. "We have an underground mine in Northern Ontario, Canada, that we call Fox Complex; we have an open pit gold mine in Nevada called Gold Bar; we have a mine on care and maintenance in Mexico that we will be reactivating shortly; and we have a joint venture in south Argentina, an underground gold and silver mine, operated by our partner, Hochschild Mining, where we own 49%; we own 100% of all the others. In addition, we have a very large copper project that we've been financing and developing independently of McEwen Mining. McEwen Mining owns 48% of this project," said McEwen in the podcast episode.

To hear the whole podcast, visit https://ibn.fm/4Tc8u

To view the full press release, visit https://ibn.fm/5cLRE

McEwen Mining Inc. (NYSE: MUX) (TSX: MUX) is an asset rich diversified gold and silver producer in the Americas with a large exposure to copper through its subsidiary, McEwen Copper, owner of the Los Azules copper deposit in Argentina, believed to be the 8th largest undeveloped copper resource in the world.

Led by a management team with a track record of success, MUX owns and operates mines in some of the most prolific gold producing regions of the Americas. The company proactively took cost-saving measures months ago to lower expenses and increase production across its portfolio of gold assets, driving some production costs below industry averages. Gold and copper prices, already in an upswing, are forecast to enter an explosive uptrend over the next couple years. Drawing from its experience, McEwen Mining planned, prepared and laid the groundwork to capitalize on this emerging opportunity.

The company currently holds a Zacks Rank #1 (Strong Buy), placing it in the top 5% of over 4,000 stocks ranked by Zacks, based on trends in earnings estimate revisions and EPS surprises. Seldom is management so aligned with investors’ interests and committed to the company’s success. With a combined investment of over $220 million, CEO Rob McEwen holds a 17% ownership stake in McEwen Mining and a 13% ownership in McEwen Copper. Acclaimed in the mining industry, McEwen founded Goldcorp, where he increased the company’s market capitalization 160 times – from $50 million to over $8 billion. That same vision and tenacity led MUX in creating McEwen Copper.

For McEwen Mining shareholders, beyond the company’s exposure to gold upsurges, its 47.7% stake in McEwen Copper is expected to be a blockbuster, turbocharging MUX by creating the world’s next prolific copper unicorn.

McEwen Copper

With continuous industrial need, new critical demand for copper is rapidly emerging, increasingly driven by the green energy transition. The price of copper rose from a low of about $2 per pound in 2020 to over $4.60 per pound in May 2024, and strong demand is expected to intensify. A study by S&P Global, titled The Future of Copper: Will the Looming Supply Gap Short-circuit the Energy Transition?, projects global copper demand to nearly double over the next decade, from 25 million metric tons today to about 50 million metric tons by 2035. Based on current trends, S&P Global forecasts annual supply shortfalls to reach nearly 10 million metric tons in 2035.

McEwen Mining owns a 47.7% equity stake in McEwen Copper, the holder of a 100% interest in the Los Azules copper project in San Juan, Argentina, which is ranked the 8th largest undeveloped copper deposit in the world. Current copper resources at Los Azules are estimated at 10.9 billion pounds at a grade of 0.40% Cu (Indicated category) and an additional 26.7 billion pounds at a grade of 0.31% Cu (Inferred category). McEwen Copper also owns a copper exploration project in Nevada, USA, called Elder Creek.

In a 2023 Preliminary Economic Assessment (PEA), Los Azules was estimated to have a 27-year life, producing an average of 322 million lbs. of copper cathode annually, at a cash cost of $1.07 per lb. of copper, in the lowest quartile of the copper cost curve. The project could ultimately become an even larger mine with a longer life, since the extent of mineralization has not been fully assessed on the property.

The project’s 2023 PEA presents a distinctly different development strategy from a prior PEA published in 2017. By proposing a heap leach project using solvent extraction-electrowinning instead of the previously detailed mine with a conventional mill and flotation concentrator, McEwen Copper aims to decrease its environmental footprint and reduce permitting risk, albeit with a lower overall copper recovery, slightly higher unit costs and a delay in immediate cashflow due to extended leach cycles.

After securing a $25 million investment from mining giant Rio Tinto’s technology arm, Nuton LLC, McEwen Copper closed its non-brokered, private placement offering of $82 million in August 2022. Shortly after, in February 2023, Nuton agreed to invest an additional $30 million into McEwen Copper, and in October 2023, Nuton once again expanded its stake, investing an additional $10 million to bring its ownership position in McEwen Copper to 14.5%.

“We are extremely pleased to have Nuton’s strong continued participation in McEwen Copper,” Rob McEwen stated in a news release. “Together we are exploring new technologies that save energy, water, time and capital in the pursuit of delivering green copper to Argentina and the world, a product that will contribute to the electrification of transportation and the protection of our atmosphere.”

Also in February 2023, FCA Argentina S.A., a subsidiary of Stellantis N.V., one of the world’s leading automakers, invested ARS $30 billion in McEwen Copper. In October 2023, Stellantis invested an additional ARS $42 billion, bringing its current stake in McEwen Copper to 19.4%.

“We are delighted to have Stellantis as a partner in the future development of our Los Azules copper project,” Rob McEwen said of the investment. “Together, we share a vision to build a mine for the future based on regenerative principles that can achieve net-zero carbon emissions by 2038.”

Following the capital raise, McEwen Copper is well-funded to advance its Los Azules Project, with a Feasibility Study planned for Q1 2025. MUX strategically reduced its interest to increase its treasury, in order to reduce debt and fund the further development of its gold and silver assets.

Gold & Silver Projects

The Fox Complex

McEwen Mining owns a 100% stake in the Fox Complex in the heart of a prolific gold district in Timmins, Canada.

“When MUX bought the Fox Complex, in late 2017, it was a distressed asset with a history of high operating cost/oz. While it has taken longer than I expected, the cost to produce an ounce of gold is significantly lower,” CEO Rob McEwen stated in a news release.

McEwen Mining issued 2024 guidance for its cash cost/oz at the Fox Complex of $1,225-1,325 on annual production of 40,000-42,000 GEOs. Fox Complex produced 44,450 GEOs in 2023, which was within the company’s guidance range.

Located in one of the most prolific gold production areas in the world, along the Destor-Porcupine Fault Zone within the Abitibi Greenstone Belt, the Fox Complex includes the Black Fox mine and Froome mine which together have yielded over 1,000,000 ounces of gold to date. Also, the complex includes the Grey Fox and Stock deposits that have over 1,800,000 ounces in gold resources. The 2.7-billion-year-old Abitibi Greenstone Belt, formed by ancient volcanic activity, has proved to be one of the world’s richest and most abundant gold regions, with a total gold content currently estimated at over 300 million ounces.

In 2024, MUX commenced development of underground ramp access to the Stock orebodies at the Fox Complex. This development will become the primary source of feed following the completion of mining the Froome deposit in 2026. As part of the future mining sequence initiative, the company has already reported a 31% year-over-year increase of gold resources at Stock West and Stock Main (historical Stock Mine), with confirmation of good grading structures plunging to depth. It has also identified Stock East as a potential new near-term source of future revenue.

The Gold Bar Mine

McEwen Mining owns a 100% stake in the Gold Bar mine, located in an area well known for gold production, the southern Roberts Mountains of the Battle Mountain-Eureka-Cortez gold trend in Eureka County, Central Nevada. The Gold Bar mine is on the same geological structure, 25 miles south of Nevada Gold Mines, a Barrick-Newmont joint venture, part of the Cortez-Goldrush complex. This complex contains estimated reserves and resources of over 50 million gold ounces, with an annual production of 1,000,000 gold ounces.

Gold Bar had been mined between 1991 and 1994, producing 134,000 gold ounces. A new facility was built by MUX in 2019. Gold Bar accounted for 42,700 GEOs in 2023, within the company’s guidance for the year. For 2024, McEwen Mining issued guidance of 40,000-43,000 at a cash cost of $1,450-1,550. The first half of the year is expected to deliver higher production relative to the second half, due to a scheduled waste stripping phase in the Pick pit, in preparation for the 2025 mining program.

Notably, in April 2024, McEwen Mining announced its entry into a definitive agreement and plan of merger with Timberline Resources Corporation (TSX.V: TBR) (OTCQB: TLRS) in a transaction valued at roughly $18.8 million. The merger with Timberline is expected to augment McEwen’s existing portfolio of development and exploration projects in Nevada, leveraging synergies between Timberline’s projects and the Company’s Gold Bar mine.

El Gallo/Fenix

Project Fenix is the proposed redevelopment plan for McEwen Mining’s El Gallo Complex in Mexico. There is a long history of mining in this region. MUX began operating it as an open pit, heap leach mine in 2013, which produced 281,000 gold equivalent ounces at average cash cost of $655 per ounce. Due to the transition to deeper sulfide mineralization that is not amenable to heap leaching, mining activities ceased in the second quarter of 2018 and residual heap leaching followed until mid-2022. The redevelopment plan envisions constructing a mill at the existing mine site that will initially reprocess the existing heap leach material, then transition to open pit mining and processing of the sulphide mineralization. The company recently acquired a complete process plant on very advantageous terms that has considerably reduced the projected capital requirements for the project.

CEO Rob McEwen stated in a news release, “This acquisition has made Fenix more attractive to build and could provide a new long life mine for McEwen Mining.”

The initial development approach is to build a mill to reprocess the material on the heap leach pad and produce approximately 17,000 oz of gold annually for eight years. Construction of the Fenix project is expected to begin in the second half of 2024.

San José Mine

McEwen Mining is a 49% owner and non-operator of the San José gold and silver mine, located in Santa Cruz province, Argentina, encircling Newmont’s prolific Cerro Negro (approx. 300,000 gold ounces produced in 2023). This high-grade underground mine has been operating since 2007 and currently has an expected life of six years with a reserve grade of 296 gpt silver and 5.4 gpt gold.

Exploration is continuing to extend high-grade veins and discover new veins at the complex. San José’s drilling programs to define additional resources and reserves have a long history of success due to a high vein density, aided by good geophysical response from hidden veins.

Production guidance for 2024 for MUX’s 49% interest is 50,000-60,000 GEOs. As a minority shareholder in the mine, MUX equity accounts for its investment in San José, and receives 49% of the dividends from the mine’s free cash flow.

Market Outlook

Mining stocks suffered significant losses in the wake of the COVID-19 pandemic. However, this has turned, and many analysts now forecast a gold bull market in 2024 and beyond.

“The operating challenges we faced in recent years have severely damaged our credibility with our shareholders and the market. As a result, few investors have taken a close look recently at our assets,” Rob McEwen said in a news release. “If they did, I believe some would see the potential value that I see today… I believe there is considerable potential value in MUX, and that is a big reason why I have a personal financial commitment of $220 million in MUX and McEwen Copper.”

Management Team

Robert R. McEwen is Chairman, CEO and Chief Owner of McEwen Mining. He has been associated with the gold industry all his career, with his first 18 years in the investment industry and, since 1990, as CEO of several gold mining companies. He founded Goldcorp and took that company from a $50 million market capitalization to more than $8 billion. He owns 17% of McEwen Mining and is in complete alignment with investors – his investment in MUX and McEwen Copper is $220 million and he takes an annual salary of only $1. He was awarded the Order of Canada and the Queen Elizabeth’s Diamond Jubilee Award, was inducted into the Mining Hall of Fame, was named an Ernst and Young Entrepreneur of the Year and has Honorary Doctor of Law degrees from York University and Western University.

William Shaver is interim COO and a Director of McEwen Mining. He has decades of management and executive experience in mine design, construction and operations. He was a founder of Dynatec Corporation, which became one of the leading contracting and mine operating groups in North America. In 2013, he was recognized as Ernst and Young Entrepreneur of the Year. Most recently, he served as COO of INV Metals. He is a Professional Engineer with a B.Sc. in Mining Engineering from Queens University.

Perry Ing is interim CFO at McEwen Mining. He has 25 years of experience in the Canadian mining industry. Over the past 15 years, he has held positions as CFO of Mountain Province Diamonds, Kirkland Lake Gold and McEwen Mining. Prior to that, he worked at Barrick Gold and Goldcorp and started his career in the mining practice at PwC. He has a Bachelor of Commerce from the University of Toronto and is a Chartered Professional Accountant in Canada and Certified Professional Accountant in the U.S.

Adrian Blanco S. is the company’s Director of Operations for America and Mexico. He has extensive international experience in several industrial sectors and has held executive positions in Mexico, the United States, Peru and Argentina. He joined the McEwen Mining team in 2015 and has led a successful business transformation toward operational discipline, best business practices and financial profitability at subsidiaries Compañia Minera Pangea and McEwen Mining Nevada. He graduated from an Executive Management Program at IPADE and Harvard Business School.

Michael Meding is Vice President and General Manager of McEwen Copper. He has over 20 years of international experience, primarily with major mining companies such as Barrick Gold and Trafigura, including extensive experience with project development and operations in Argentina. While at Barrick Gold’s Veladero mine in Argentina, Mr. Meding played a key role in the turnaround, extension of the mine life and subsequent strategic partnering with Shandong Gold. He holds an MBA from Indiana University in Pennsylvania and an MBA from the Leipzig Graduate School of Management in Germany.

McEwen Mining Inc. (NYSE: MUX), closed Thursday's trading session at $10.26, off by 1.7241%, on 560,227 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $5.92/$12.50.

Recent News

Astrotech Corp. (NASDAQ: ASTC)

The QualityStocks Daily Newsletter would like to spotlight Astrotech Corp. (NASDAQ: ASTC).

Farmers in Idaho are set to plant almost two times as much hemp this year as they did in 2023. Data from the state's department of agriculture shows that last year, state farmers planted more than 1,200 acres of hemp. This is more than three times the hemp planted in 2022 when the state permitted farmers to begin cultivating the industrial crop. As of May 31, 2024, the state's department of agriculture had approved licenses to grow hemp on 2,440 acres. Growers wishing to venture into this space are advised to educate themselves on different variables. The growing production of hemp in Idaho and other parts of the country could create a vibrant market for entities such as Astrotech Corp. (NASDAQ: ASTC) that focus on making a variety of testing equipment for medical and industrial use.

Astrotech (NASDAQ: ASTC), an innovative science and technology company, in Austin, Texas, June 13, 2024 (GLOBE NEWSWIRE) -- AgLAB, Inc., ("AgLAB") a subsidiary of Astrotech Corporation (NASDAQ: ASTC) ("Astrotech", or the "Company"), and SC Labs announced today that the companies will be jointly marketing the AgLAB 1000-D2 TM mass spectrometer and the AgLAB Maximum Value Process testing method ("AgLAB MVP"), to SC Labs customers. This comes with the companies entering into a master lease agreement. AgLAB has pioneered applications utilizing the Astrotech Mass Spectrometer Technology that are tailored to the hemp and cannabis markets. The AgLAB MVP method is designed to improve yields and bottom-line profits for hemp (CBD) and cannabis (THC) producers of distilled oils used in various products. Large scale oil producers typically use high vacuum molecular distillation systems ("MDS") to produce the valuable oils that are used in lotions, pills, tinctures, and cartridges. Using the AgLAB MVP solution, manufacturers can analyze the oils during processing and make near real-time adjustments to temperatures and pressures that boost the ending-weight yields, potencies, and profits.

Astrotech Corp. (NASDAQ: ASTC) is an instrumentation company that designs, manufactures and commercializes solutions. Its solutions include mass spectrometry, process controls, chemical detectors and medical disease detection.

The company was established in 1984 and, prior to 2009, was known as SPACEHAB Inc., a NASA contractor offering technology originally developed for NASA to monitor air quality on the International Space Station. When the Space Shuttle program ended, the company focused on its satellite processing and mass spectrometer instrumentation units and adopted the Astrotech name.

In 2014, Astrotech sold its satellite subsidiary to focus on its Astrotech Technology Inc. (ATi) mass spectrometry solutions, which offer a number of advantages over competing platforms. Notably, Astrotech’s ATi technology is ruggedized, rapid, simple to use and customizable, with hands-free calibration and tuning.

Between 2016 and 2019, the company secured U.S. patents for its technology and achieved European Union (ECAC) certification for the TRACER 1000™, the world’s first mass-spec Explosives Trace Detector (ETD) used in airports worldwide. Astrotech continues to innovate and add to its suite of products, including AgLAB-1000, a process control system, and the BreathTest 1000, a disease detection solution.

Astrotech is headquartered in Austin, Texas.

Subsidiaries

Astrotech Technologies Inc.

Astrotech Technologies Inc. (ATi) owns and licenses the platform mass spectrometry technology originally developed by 1st Detect. This technology is designed to be less expensive, smaller and easier to use than traditional mass spectrometers.

Unlike other technologies, ATi works under high vacuum, which eliminates competing molecules, yielding higher resolution and fewer false alarms. The company’s intellectual property includes 18 granted patents, along with extensive trade secrets.

ATi exclusively licenses the Astrotech Mass Spectrometer Technology to the three wholly owned subsidiaries of Astrotech.

1st Detect Corp.

1st Detect Corp. developed the TRACER 1000, the world’s first mass spectrometry-based explosives and narcotics trace detector. 1st Detect ETDs were developed for use at airports, cargo facilities and other secured locations and borders worldwide.

1st Detect’s commercial sales of the TRACER 1000 ETD, consumables and recurring maintenance services brought in $750,000 in total revenue during the fiscal year ended June 30, 2023. The Astrotech subsidiary recently secured two orders for a total of 24 Tracer 1000 units from two Romanian security and telecommunications companies, to be delivered during calendar 2023.

AgLAB Inc.

AgLAB Inc. is developing a series of mass spectrometers for use in the hemp and cannabis market, with an initial focus on optimizing yields in the distillation processes.

AgLAB, which uses the company’s proprietary AgLAB 1000-D2™ mass spectrometer, has been proven to improve distillation oil yields and bottom-line profits for hemp and cannabis producers. During field trials, AgLAB was able to improve ending-weight yields by an average of 24%.

BreathTech Corp.

BreathTech is developing the BreathTest-1000™, a breath analysis tool to screen for volatile organic compound (“VOC”) metabolites found in a person’s breath that could indicate they may have a compromised condition including but not limited to a bacterial or viral infection. The company believes that new tools to aid in the battle against COVID-19 and other diseases remain of the utmost importance to help more quickly identify that an infection may be present.

Market Opportunity

A report by Mordor Intelligence, a research and advisory firm, put the global mass spectrometry market at $6.37 billion in 2023. The market is forecast to grow to $8.63 billion by 2028, achieving a CAGR of 6.25% during the forecast period.

One of the major driving factors for the growth of the mass spectrometry market is technological advancements in mass spectrometer devices, the report states. Key market players are continuously working toward advancing their existing products and launching innovative and advanced mass spectrometer devices.

Another major factor that is expected to boost market growth is increasing research and development expenditure by both government and private entities, according to the report. Mass spectrometry devices are also being used in the detection and analysis of COVID-19 and other disease samples, which may have a positive impact on the market.

Management Team

The Astrotech leadership team includes management executives, as well as industry and technology experts. The company continues to actively expand its talent pool to meet evolving demands.

Thomas B. Pickens III is Chairman, CEO and Chief Technology Officer of Astrotech Corp. He also serves as CEO of Astrotech subsidiaries ATi, 1st Detect, AgLAB Inc. and BreathTech Corp. Previously, he was the founder and president of Beta Computer Systems Inc. and T.B. Pickens & Co. He was founder and general partner of Grace Pickens Acquisition Partners L.P and managing partner of Sumpter Partners. He also served as CEO of Catalyst Energy Corporation and United Thermal Corporation and as president of Golden Bear Corp., United Hydro Inc. and Slate Creek Corp. He received a B.A. in Economics, Computer Science and Engineering from Southern Methodist University.

Jaime Hinojosa, CPA, is CFO at Astrotech Corp. He joined the company in 2015 and has served as its Corporate Controller since 2019. His previous roles with the company include Director of Finance, from 2017 to 2019, and Assistant Controller, from 2015 to 2017. Prior to joining Astrotech, Mr. Hinojosa worked as an Accounting Manager for O’Reilly Auto Parts and gained public accounting experience as an Audit Manager at Burton McCumber & Cortez LLP.

Astrotech Corp. (NASDAQ: ASTC), closed Thursday's trading session at $8.8301, off by 2.9115%, on 16,272 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $7.00/$15.11.

Recent News

Mullen Automotive Inc. (NASDAQ: MULN)

The QualityStocks Daily Newsletter would like to spotlight Mullen Automotive Inc. (MULN).

Bloomberg analyst projects 2024 EV sales in the U.S. at nearly 2 million units, making up 13% of new-car purchases

Mullen subsidiary inks first commercial dealership agreement with LaFontaine Automotive Group

Bollinger Motors expects to start delivering the Bollinger B4 later this year

While some headlines in the past few months make it seem like the electric vehicle market is in trouble, a recent "Car and Driver" article forecasts that EV sales are just getting started. Mullen Automotive (NASDAQ: MULN), an emerging EV manufacturer, appears to support that projection, with the recent announcement that its subsidiary, Bollinger Motors, has entered a distribution deal with LaFontaine Automotive Group to become its first commercial dealership (https://ibn.fm/G0kGO).

Mullen Automotive (NASDAQ: MULN), an electric vehicle ("EV") manufacturer, today announced that its subsidiary, Bollinger Motors, has reached an agreement to sell 80 all-electric Class 4 commercial trucks for a sales order of $13.2 million to Momentum Groups, a leader in fleet management and EV charging solutions. Momentum, with strength is in its full-service national fleet program and mobile or permanent charging infrastructure for EVs, can upfit the Bollinger B4 Chassis Cab with mobile EV chargers, a box truck, flatbed, service body or stake truck. According to the announcement, Momentum will take possession of the vehicles after Bollinger Motors launches production in the second half of 2024. "Momentum is a leader and innovator in mobile charging solutions and has a shared commitment to using electric vehicles as part of a fleet management solution to help companies reduce emissions and save money," said Robert Bollinger, founder and CEO of Bollinger Motors. "We are excited that the Bollinger B4 will be the Class 4 platform that helps Momentum deliver a mobile-charging solution."

To view the full press release, visit https://ibn.fm/qHvjL

Mullen Automotive Inc. (NASDAQ: MULN) is a Southern California-based automotive company that owns and partners with several synergistic businesses working toward the unified goal of creating clean and scalable energy solutions. Mullen has evolved over the past decade in sync with consumers and technology trends. Today, the company is working diligently to provide exciting EV options built entirely in the United States and made to fit perfectly into the American consumer’s life. Mullen strives to make EVs more accessible than ever by building an end-to-end ecosystem that takes care of all aspects of EV ownership.

Commencement of Trading on Nasdaq

On November 5, 2021, Mullen announced its commencement of trading on the Nasdaq Capital Market.

“Today is a monumental day for Mullen Automotive. I am especially proud of our team, investors and all who have believed in Mullen and taken us to this point as a publicly traded company on the Nasdaq Capital Market,” David Michery, CEO and Chairman of Mullen Automotive, stated in the news release. “Trading on Nasdaq now opens us up to new investors, both institutional and retail shareholders, and broadens our awareness and company profile, while increasing awareness of Mullen and our technology platform and opening new opportunities in EV and beyond. The road ahead has never been brighter for Mullen, and I am proud to lead us into the future.”

The milestone came in the wake of the company’s stock-for-stock merger with Net Element Inc.

The Mullen FIVE

The Mullen FIVE EV Crossover, debuting at the Los Angeles International Auto Show (LAIAS) on November 17, 2021, embodies Mullen’s Southern California roots with an inspired design focused on two complementary Golden State themes – California landscape and California urban.

The FIVE is built on an EV Crossover skateboard platform that offers multiple powertrain configurations and trim levels in a svelte design that is Strikingly Different™ and exciting to experience in person.

Prior to the start of LAIAS, the Mullen FIVE was selected as a finalist by the LA Auto Show for Top EV SUV in the ZEVA “People’s Choice” Awards.

LAIAS provides Mullen an opportunity to display multiple variants of the FIVE model while also showcasing its powertrain, battery and charging technology. The company intends to bring the FIVE to market in 2024, and reservations are currently open here.

Mullen’s development portfolio also includes EV Fleet Vans, which it intends to bring to market in Q2 2022, and the pure electric, high performance Mullen DragonFLY.

Expansion of Manufacturing Capacity

On November 2, 2021, Mullen announced plans to expand its facility in Robinsonville, Mississippi.

Mullen’s Advanced Manufacturing and Engineering Facility (AMEC) currently occupies 124,000 square feet of manufacturing space. The total available land on the property is over 100 acres, and Mullen is moving ahead with plans to build out another 1.2 million square feet of manufacturing space to support class 1 and class 2 EV cargo vans and the Mullen FIVE EV Crossover.

On the expanded site, Mullen plans to build a body shop, a fully automated paint shop and a general assembly shop.

EV Market Outlook

The global EV market was reported to consist of 3,269,671 units in 2019, a figure that is expected to grow at a CAGR of 21.1% through 2030 to a total of 26,951,318 units worldwide. This market’s monetary value was estimated at $162.34 billion in 2019 and is expected to grow at a CAGR of 22.6%, resulting in an approximate value of $802.81 billion by 2027. The primary driver for this exponential growth is a worldwide increase in vehicle emissions regulations.

Management Team

David Michery is the CEO and Founder of Mullen and has been leading the company and its divisions since inception in 2014. With over 25 years of executive management, marketing, distressed assets, and business restructuring experience, Mr. Michery brings a wealth of relevant knowledge and expertise to the Mullen brand. He has notably created 12 trademarks so far to develop the company brand and vision.

Mr. Michery is working toward a sustainable future accessible to all by creating a suite of clean-energy electric vehicles at varied price points. With entirely U.S.-based manufacturing and operations, he is also determined to have Mullen Technologies play a role in shaping a self-sustaining local economy by creating more jobs in America.

Mr. Michery manages risks and company expectations as a pathway to success and has personally overseen several businesses that totaled over $1 billion in transactions. His key strength is the ability to be fiscally responsible and lead teams to complete projects on time and within budget. As a seasoned professional in this space, Mr. Michery has demonstrated skill in building businesses from the ground up and into successful entities that subsequently sold for hundreds of millions of dollars.

Mullen Automotive Inc. (MULN), closed Thursday's trading session at $2.67, off by 4.6429%, on 2,612,287 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $2.3565/$324.90.

Recent News

Reunion Gold Corp. (TSX.V: RGD) (OTCQX: RGDFF)

The QualityStocks Daily Newsletter would like to spotlight Reunion Gold Corp. (TSX.V: RGD) (OTCQX: RGDFF) .

Reunion Gold (TSX.V: RGD) (OTCQX: RGDFF), a leading gold explorer in the Guiana Shield, has scheduled an annual general and special shareholders meeting. The meeting will be held July 9, 2024, with agenda items that include voting and approving an arrangement with G Mining Ventures. According to the announcement, shareholders will vote to approve a statutory plan of arrangement entered into between Reunion Gold, G Mining Ventures Corp. and Greenheart Gold Inc. The arrangement calls for a new entity to be incorporated to hold and manage the combined business of Reunion Gold and GMIN; the new entity will acquire all of the issued and outstanding common shares in the capital of Reunion Gold as well as GMIN. Reunion Gold will be mailing the joint management information circular and other related materials for the upcoming meeting to holders of Reunion Gold common shares and holders of options to purchase Reunion Gold common shares. A special committee of the Reunion Gold board of directors was created to consider the arrangement; committee members reviewed the arrangement and unanimously recommend that the Reunion Gold board approve the arrangement agreement and recommend that Reunion Gold voting securityholders vote in favor of the arrangement resolution. Other agenda items to be voted on and considered during the meeting include receiving and considering the annual consolidated financial statements of Reunion Gold for the financial year ended Dec. 31, 2023; the election of company directors for the ensuing year; the appointment of Raymond Chabot Grant Thornton LLP as the company's independent auditor; and the consideration and possible approval of an ordinary resolution ratifying and approving Reunion Gold's amended and restated share option plan and an ordinary resolution approving the adoption of the Spinco share option plan.

To view the full press release, visit https://ibn.fm/R0xH0

Reunion Gold Corp. (TSX.V: RGD) (OTCQX: RGDFF) is a leading gold explorer in the Guiana Shield, South America. In early 2021, the Company announced an exciting new greenfield gold discovery at its Oko West project in Guyana, where, after 22 months of resource definition drilling, the Company has announced an initial Mineral Resource Estimate (MRE) containing 2.475 Moz of gold in Indicated resources at 1.84 g/t and 1.762 Moz of gold in inferred resources at 2.02 g/t contained within a pit shell outline. Preliminary metallurgy results performed by the company, consisting of 8 bottle roll tests obtained strong results, averaging just under 90% recoveries on average. The Company is continuing with additional development activities at Oko West, including environmental base line studies and additional metallurgical work relating to the delivery of a PEA by year end 2023. In addition, Reunion Gold is currently exploring several priority targets in the Oko West project area on which the company feels there is good potential to add additional resource ounces. This includes the opportunity to grow the initial mineral resource estimate (MRE) released on June 13, 2023, and to discover additional gold ounces at Oko West outside of the resource area.

The Guiana Shield remains one of the most prospective exploration locations globally for the discovery of world class orogenic gold deposits. The shield, including both Guyana and Surinam, contain large relatively underexplored greenstone belts, from which Reunion Gold expects many more significant gold discoveries could emerge in the coming years.

Oko West Project

Reunion Gold’s Oko West Project is a brand-new gold discovery in northwest Guyana located within the historical Oko gold district. Alluvial gold has been mined from the Oko district since the turn of the century, but very little primary gold has been mined or even explored for to the best of the company’s knowledge. The project comprises a prospecting license with an area of approximately 44 square kilometers and is 100% held by Reunion’s Guyanese subsidiary.

In 2020, Reunion Gold’s geochemical survey, trenching and initial 1000 m drill program discovered and confirmed the presence of gold mineralization in this Orogenic gold system. The gold occurs in the eastern edge of the project area, along a 6km long sheared contact between a granitoid intrusion and a meta volcanic-meta sedimentary rock package. The MRE is located within the Kairuni zone, which represents the northern most 1.9 km of the 6 km long contact.

“We are advancing our Oko West project along two tracks. The first is to advance the exploration programs outside of the Kairuni zone, aimed at outlining and discovering additional gold mineralization within our Prospecting License. On this front, I am very excited by the results from the initial Scout RC Geochem drill program that is defining new targets west of our Kairuni zone,” Rick Howes, President and CEO of Reunion Gold, stated in a recent news release. In addition to the targets west of the Kairuni zone, the company has also commenced exploration work on the southern ~ 4 km of the same sheared contact that hosts the Kairuni zone MRE. In addition, the company feels that the MRE marks the size of the Kairuni resource at a point in time and that there is good potential to continue to grow the resource. The MRE remains open at depth below the resource pit outline in the block 4 area and also to depth and along strike in the block 5 and 6 areas. In addition to the exploration programs, the second strategic track is to rapidly advance the Kairuni zone along the path to development. To that end the company is moving forward with the engineering and other studies, including more detailed metallurgical studies, that will support the release a PEA on the Kairuni zone by year end 2023 The company feels that the rapid advancement of development of Kairuni zone MRE, while in parallel continuing to explore for additional ounces on the project, is the best path to try and maximize shareholder value in the shortest period of time.

Guyana

Guyana boasts a long history of mining gold, bauxite, diamonds and manganese. Still, the greenstone belts of the Guiana Shield remain relatively unexplored when compared to the analogous regions of the West African Shield (Birimian), which, according to geological evidence, was once connected to the Guiana Shield, forming a contiguous craton prior to the Mesozoic period.

Despite a historical lack of accessibility and low exploration intensity, several significant large-scale projects have emerged in the Guiana Shield, including Aurora, Oko West, Oko Main, Toroparu and Omai. Guyana is English speaking with a British based parliamentary and legal system and boasts the world’s fastest growing economy on the back of significant offshore oil discoveries by Exxon and its partners. It is expected that a significant amount of the revenues from oil production will be invested in improving the infrastructure, education and health care and agriculture within the country.

Market Opportunity

The World Gold Council, an industry association representing gold producers with hundreds of mining operations in nearly 50 countries around the world, called 2022 the “strongest year for gold demand in over a decade.” Annual gold demand jumped 18% YoY due to “colossal central bank purchases, aided by vigorous retail investor buying and slower ETF outflows.”

Despite this spike in demand, total annual gold supply increased by just 2% in 2022, halting two years of successive declines but failing to challenge 2018 highs. This supply-demand imbalance could provide a favorable market environment as Reunion Gold continues to advance drilling programs at its 100%-owned Oko West Project.

Management Team

Successful exploration and the discovery of significant deposits in any given region require immense amounts of local knowledge and experience. This is the principle around which Reunion Gold has built its management team. In total, the company’s leadership boasts over 225 years of combined experience in the Guiana Shield.

David Fennell is the Executive Chairman of Reunion Gold, a position he has held since the company’s inception in 2003. He has 40 years of experience in the mining industry. He received a law degree from the University of Alberta in 1979 and practiced law until he founded Golden Star Resources Ltd. in 1983. During his term as President and CEO, Golden Star became one of the largest and most successful exploration companies. While at Golden Star, he was instrumental in the discovery and development of the Omai Gold Mine in Guyana and the Gross Rosebel Mine in Suriname. In 1998, Mr. Fennell became Chairman and CEO of Hope Bay Gold Corporation. He held this position through the merger of Hope Bay and Miramar Mining Corporation and remained as Executive Vice-Chairman and Director for the combined entity until its takeover by Newmont Mining Corporation in 2008. Mr. Fennell is currently a member of the board of directors of G Mining Ventures Corp. and Sabina Gold & Silver Corp.

Rick Howes, P.Eng., is the company’s President and CEO. He is a seasoned mining executive with over 39 years of experience in the mining industry, most recently as CEO of Dundee Precious Metals. Mr. Howes has extensive operating, technical and project development experience in both underground and open pit mines throughout Canada and internationally. In 2009, Mr. Howes joined Dundee Precious Metals, where, as VP and General Manager, he led the transformation of the Chelopech Mine in Bulgaria to reach world-class levels of performance. He became COO in 2011 and oversaw several significant growth capital development projects, including the expansion of the Chelopech Mine, the upgrade and expansion of the Tsumeb Smelter in Namibia and the development of the greenfield Ada Tepe open pit gold mine in Bulgaria. He was appointed CEO in April 2013, leading Dundee’s transformation from a junior gold producer to a multi-asset mid-tier gold producer generating strong free cashflow and solid returns to shareholders. Mr. Howes has been recognized as a visionary leader in mining, organizational innovation and transformation and was recognized as the Outstanding Innovator of 2016 by the International Mining Technology Hall of Fame.

Alain Krushnisky is the CFO of Reunion Gold. He brings to the company years of experience in the mining sector, including 10 years with Cambior Inc. (now IAMGOLD) in capacities such as Vice-President and Controller. Since 2004, Mr. Krushnisky has been doing consulting work for various publicly listed exploration and mining companies. He graduated from the University of Ottawa in 1983 with a bachelor’s degree in commerce and is a Chartered Professional Accountant.

Justin van der Toorn is the company’s VP Exploration. He is an exploration geologist with 18 years’ experience in the minerals industry, leading and managing exploration teams from grassroots activities through to discovery and resource definition drilling. Mr. van der Toorn’s previous experience has been in a range of commodity and deposit styles, including extensive work in Carlin-style gold, low- and high-sulphidation epithermal, porphyry and orogenic gold systems. He holds an MSci degree in Geological Sciences from the Royal School of Mines, Imperial College London. He is registered as a Chartered Geologist (CGeol) of the Geological Society, and a European Geologist (EurGeol) by the European Federation of Geologists.

Doug Flegg is the company’s business Development advisor. Doug has over 35 years’ experience in mining and mining finance with senior positions in research, portfolio management and global equity sales. Previously, Mr. Flegg was Managing Director Global Mining Sales with BMO Capital Markets where he was involved in raising $35 billion in over 200 corporate financings. Since 2016 he has been providing business development, strategic, and financing advice to corporate mining clients. Mr. Flegg also has a B.Sc. in Geology, work experience as a geologist and an MBA from Queens University.

Reunion Gold Corp. (OTCQX: RGDFF), closed Thursday's trading session at $0.440742, off by 0.3297151%, on 175,450 volume. The average volume for the last 3 months is 146,242 and the stock's 52-week low/high is $0.24/$0.492.

Recent News

Torr Metals Inc. (TSX.V: TMET)

The QualityStocks Daily Newsletter would like to spotlightFathom Torr Metals Inc. (TSX.V: TMET) .

Torr Metals (TSX.V: TMET), a mineral exploration company focusing on the identification, acquisition and advancement of mineral properties, is reporting final assay results from the 2023 rock sampling program; the report also noted the delineation of a robust ZTEM geophysical anomaly at the newly defined Vik Zone, located at the Kolos Copper-Gold Project. Highlights of the report show outcrop mineralization coincident with 2023 soil anomalies, new robust ZTEM geophysical anomalies in the east and major copper discovery potential. The company also reported that it has completed its early reconnaissance field sampling program, which included coverage over newly acquired ground to the north and east assays pending for 27 outcrop and float rock grab samples. "We are strongly encouraged by these promising results, which validate our meticulous exploration strategy at the Kolos Project," said Torr Metals president and CEO Malcolm Dorsey in the press release. "The rock grab sample grades are in-line with comparisons we have made in the region, and we have confirmed surface mineralization in outcrop within all of our high-priority target zones, positioning us with prime starting locations for future drilling. With the recent expansion, we have identified and sampled new exploration targets, strengthening our position for the upcoming 2024 field season with potential for multiple new grassroots discoveries in addition to our established drill-ready targets, significantly enhancing the long-term growth potential of our project and driving further value for our shareholders."

To view the full press release, visit https://ibn.fm/tjff1

Torr Metals Inc. (TSX.V: TMET) operates as a mineral exploration company focusing on the identification, acquisition, and advancement of mineral properties. With full 100% ownership of over 1,000 square kilometers of gold and copper projects strategically positioned in premier low-cost mining jurisdictions, Torr is poised for substantial returns across various promising regions.

The company’s extensive portfolio encompasses multiple district-scale projects, including the Filion Gold Project in northern Ontario, the Kolos Copper-Gold Project in south-central British Columbia, and the Latham Copper-Gold Project in northern British Columbia. These projects are all located in prolific mining regions with paved highway access, robust support infrastructure, and favorable geological conditions offering significant potential for new discoveries.

Headquartered in Vancouver, British Columbia, Torr Metals is ideally situated to leverage its expertise and resources for continued exploration and growth.

Projects

Kolos Copper-Gold Project

Situated within British Columbia’s prime copper-producing belt, the 140-square-kilometer Kolos Copper-Gold Project exhibits Nicola Belt geology similar to notable porphyry mines, including Copper Mountain and Highland Valley, respectively situated 106 kilometers to the south and 30 kilometers to the northwest.

With field operations based in the nearby city of Merritt and year-round access provided via Highway 5, the Kolos Project showcases substantial discovery upside potential with five defined large-scale copper-gold-molybdenum anomalies untested by drilling.

Torr Metals’ primary focus lies in unlocking the potential for major new discoveries at the Kolos Copper-Gold Project, with recent surface geochemical results marking a significant milestone positioning the company as a new key player in the region.

Filion Gold Project

The 261-square-kilometer Filion Project is situated within a largely unexplored greenstone belt where gold was initially discovered in the 1930s. With a comparable geological setting to regional orogenic gold deposits and multiple newly identified and undrilled gold trends in surficial geochemistry, the Filion Project holds significant district-scale exploration promise.

The Filion Project benefits from unparalleled infrastructure access, with direct drive-on access from the Trans-Canada Highway, as well as a regional railway and power grid four kilometers to the south. Additionally, the nearby town of Kapuskasing, with a population of 8,300, provides essential support services.

This strategic positioning ensures the Filion Project’s viability for cost-effective, year-round operations in an area poised for untapped discovery potential.

Latham Copper-Gold Project

Situated in British Columbia’s renowned Golden Triangle, the Latham Project spans a vast 689-square-kilometer district, offering immense potential for multiple major discoveries. Accessible year-round via Highway 37, just 20 kilometers south of the town of Dease Lake, the site is strategically located amidst established mining infrastructure, including the active Red Chris mine to the southeast and upcoming major porphyry projects at Schaft Creek and Galore Creek along-trend to the southwest.

Highlighted by the Gnat Pass copper-gold porphyry deposit dating back to the 1960s, the Latham Project presents a compelling opportunity for significant expansion and potential discovery. A non-compliant indicated resource at the Gnat Pass deposit includes 33 million tonnes at 0.39% copper, open beyond 200 meters vertical depth, alongside six drill-ready kilometer-scale copper-gold exploration targets.

Moreover, the Latham Project’s appeal corresponds to the region being an attractive destination for major asset acquisitions and takeovers. Recent transactions within a 40-kilometer radius include Newmont’s 2021 acquisition of the Saddle North copper-gold porphyry deposit for $311 million and Newcrest’s investment in the Red Chris copper-gold porphyry deposit in 2019 for $804 million, underscoring industry acknowledgment of the region’s potential.

Market Opportunity

The World Gold Council, the industry association for the world’s gold producers, estimated in 2023 that the physical financial gold market, which is made up of bars, coins, gold ETFs and central bank reserves, is worth nearly $5 trillion.

The council reports that gold mine production adds approximately 3,500 tons of the precious metal to the world’s supply annually, equivalent to about 2% growth. This historical scarcity and relatively slow production of new supply, as compared to other commodities, is a primary reason gold has retained its value for millennia, according to the council.

Likewise, a report from Acumen Research and Consulting, a global provider of market intelligence and consulting services, valued the global copper market at $304.1 billion in 2022 and forecast that it will reach a market size of $496.8 billion by 2032, growing at a CAGR of 5.1% over the forecast period.

The report identifies a growing demand for copper in the electronics industry, as well as an expanding copper supply due to increasing production from existing mines and the rising number of mine development projects in developing nations, as driving factors in the rising value of the copper market.

Management Team

Malcolm Dorsey, P.Geo., is President, CEO and Director of Torr Metals. He brings over a decade of expertise as a seasoned exploration geologist and project developer, having been pivotal in driving the success of numerous diverse projects across North, Central, and South America. His comprehensive background spans early-stage exploration through to resource development and project acquisitions. His academic credentials include an M.Sc. in Geology and Geophysics from the University of Calgary, where his research characterized the district-scale structural influences affecting copper and gold mineralizing events in western British Columbia. Prior to his current role, he served as Senior Geologist for Benchmark Metals, where his contributions were instrumental in advancing the company’s gold equivalent resource from approximately 80,000 ounces to a maiden resource estimate of 2.92 million ounces.

John Williamson, P. Geol., is Chairman and Director of Torr Metals. He is a mining executive and investor with more than 30 years of experience as a founder, promoter and leader in the formation, financing and operation of private and public companies with exploration and mining interests worldwide. On more than one occasion his team’s efforts have been recognized for excellence by being named to the TSX Venture 50. He holds a B.Sc. in Geology and is a registered Professional Geologist (P.Geol.) with the Association of Professional Engineers and Geoscientists (APEGA) and the Geological Association of Canada.

Torr Metals Inc. (TSX.V: TMET), closed Thursday's trading session at $28.7031, off by 1.1601%, on 76 volume. The average volume for the last 3 months is 100 and the stock's 52-week low/high is $24.01/$31.90.

Recent News

FingerMotion Inc. (NASDAQ: FNGR)

The QualityStocks Daily Newsletter would like to spotlight FingerMotion Inc. (NASDAQ: FNGR) .

Alipay, the dominant mobile wallet provider in China, has unveiled an artificial-intelligence (AI)-based mini app that can help people detect whether they are balding. One simply uploads four images of their head in order to be assessed for balding. This mini app marks yet another way that the mobile payment giant is seeking to further entrench itself in many aspects of people's lives so that it isn't viewed as simply a mobile payment channel. The hair-loss detection mini app isn't the company's first foray into the healthcare space. In April, the company launched an AI health assistant that can perform many tasks, including recommending which medical specialties users need to consider to address the issues they face. The assistant also updates users who are queuing to see their doctors. Alipay has leveraged its position as one of the market leaders in China's mobile payments system, and this is helping the company deepen its reach in various verticals. Its success shows the different roles that mobile payments providers such as FingerMotion Inc. (NASDAQ: FNGR) can play in the communities where they operate.

FingerMotion Inc. (NASDAQ: FNGR) is an evolving technological company with core competencies in mobile payment and recharge platform solutions in China. FingerMotion is in the process of developing additional value-added technologies to market to users.

Founded in 2016, FingerMotion’s goal is to serve over a billion users in the Chinese market and expand its model to other regional markets. The company has offices in Hong Kong, Shanghai and New York City.

Current Offerings

FingerMotion is analyzing and transforming mobile data to improve the lifestyle of the public through technology and innovation. The company’s current offerings include:

  • Telecommunications Products and Services – FingerMotion’s proprietary universal exchange platform, ‘PigeonHole Integration System (PIS)’, offers seamless integration between telecom operators and online stores. The service platform’s offerings include top up and recharge, data plan, mobile phone, loyalty points redemption and subscription plans. The platform offers reliable and secure transactions, real-time reconciliation, simple integration for partners and efficient settlements.
  • SMS and MMS Services – The integrated platform is registered as FingerMotion’s IP in China and provides a robust back-end control panel for corporate partners to manage their own messaging settings. FingerMotion’s clients range from insurance to financial industries, ecommerce firms, airlines and more. The platform offers competitive pricing for partners and provides quick and efficient review to meet timely marketing initiatives.
  • Big Data Insights – FingerMotion brings Big Data-enabled insurance solutions through its Big Data Insights arm, Sapientus. The company’s strategic partnerships with the largest Chinese telecommunications giants allow access to uncover behavior insights through geolocation and mobile data usage. Its Big Data offerings include risk scoring, precise marketing, simplified underwriting and customized products.
  • Rich Communication Services (RCS) – FingerMotion’s RCS platform will be a proprietary business messaging solution that enables businesses and brands to communicate their services to customers via 5G infrastructure. The company expects its RCS platform to offer a better user experience, more efficiency and cost-effectiveness when compared to other solutions.

Telecommunications and Insurtech Markets

The global telecommunications market was valued at $1.74 trillion in 2019 and is expected to grow at a CAGR of 5% from 2020 to 2027. The steady increase is expected to be driven by the adoption of 5G and the increased popularity of Internet of Things (IoT) applications.

The Chinese telecom market was valued at $254.1 billion in 2017 and is also constantly expanding. The current Chinese telecom market is dominated by three mobile operators – China Mobile, China Unicom and China Telecom, which together are responsible for around 1.6 billion active subscribers (https://ibn.fm/zfwy9).

In addition, the insurtech (insurance technology) market was valued at $2.72 billion globally in 2020 and is expected to grow at a CAGR of 48.8% from 2021 to 2028. The large increase is attributed to the rising use of technology solutions for everyday activities like acquiring insurance coverage (https://ibn.fm/TGo7D).

Through its proprietary platforms and technologies, FingerMotion is uniquely positioned to capitalize on the telecom and insurtech markets’ growth and opportunities.

Management Team

Martin J. Shen is the Chief Executive Officer of FingerMotion Inc. He has over 15 years of experience in senior management roles within entrepreneurial startups and large multinational corporations. He has acquired a wide range of corporate management, financial oversight and operation administration expertise through these roles. In his most recent role, he founded Imperial Distributors (formerly known as AP Martin Pharmaceutical Supplies Ltd.), establishing the company as the preferred choice for distributional support to regional pharmacies throughout Western Canada. Before founding Imperial, Mr. Shen served as the Chief Operating Officer and Chief Financial Officer at Wales and Son Industrial (formerly Weir Minerals), a firm specializing in global delivery and support for mining slurry equipment. He began his career at PricewaterhouseCoopers in Vancouver, with work tours in the tax department in Singapore and the tax audit and advisory group in Hong Kong. Mr. Shen is a U.S. Certified Public Accountant and holds a Bachelor of Science from the University of British Columbia.

Lee Yew Hon is the company’s Chief Financial Officer. From 2006 until November 2020, he was the Chief Financial Officer of Cubinet Interactive Group of Companies, and he also took on the Chief Operating Officer role in 2011. During his tenure, he was instrumental in leading Cubinet and building teams across the Southeast Asia region, setting up financial processes within a short time. Mr. Lee spearheaded the growth of Cubinet to other regions, including Europe, the Middle East and Russia. He received his diploma from Tunku Abdul Rahman College in 1996. He is a Chartered Accountant, a member of the Malaysia Institute of Accountants (MIA) and an Associate Member of the Chartered Institute of Management Accountants, UK (ACMA).

Li Li is the Senior Vice President of FingerMotion. She recently served as Advisor to Shenzhen WuYiKa Technology Co. Ltd., a comprehensive service platform dedicated to online service distribution and payment. The company has become a fast and efficient provider of new media marketing solutions for the mobile internet. She has held high-level management positions with multiple industry names, including Hangzhou JiuYue Information Technology Co. Ltd. and Hangzhou LingXuan Information Technology. Ms. Li started her career in 2004, founding Shanghai ChuangYeZZ Network Technology Co. Ltd. and serving as its Vice President. With the close cooperation of local operators, the company launched SMS, MMS, WAP, mobile JAVA games, Hunan Satellite TV e-magazine and other wireless internet services to meet the rapid development of wireless internet and application requirements. She received her degree from Nanjing Academy of Engineering.

FingerMotion Inc. (FNGR), closed Thursday's trading session at $2.79, up 0.3597122%, on 173,878 volume. The average volume for the last 3 months is 353,325 and the stock's 52-week low/high is $1.38/$7.97.

Recent News

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPRMissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPRMissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.